TSS:Rfhg 97574.1

Basic information about the TSS

---

TSS ID: rfhg_97574.1 Species: human Chr: chr7		Start: 100676149 End: 100676179 Strand: +
Source datasets
Protocol
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000393924.1:-11 GeneID: 2783 HGNC/MGI_ID: HGNC:4398 UniProt_ID: Q6FHM2 Nearer transcript ids and distances:

Gene_name: GNB2 Gene_symbol: GNB2 Gene_synonyms: Gene_source: HGNC:4398

TATA-Box annotation

---

Distance to TSS:	2424
Nearest PromoterID:	NM_005273
Entrez ID:	2783
Nearest Unigene:	Hs.185172
Nearest Refseq:	NM_005273
Nearest Ensembl:	ENSG00000172354
Gene Name:	GNB2
Gene Alias:	-
Gene Type:	protein-coding
CpG%:	0.033333
GC%:	0.741935
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@GNB2 p2@GNB2 p3@GNB2 p4@GNB2 p5@GNB2 p7@GNB2 p8@GNB2
Sample		p1@GNB2	p2@GNB2	p3@GNB2	p4@GNB2	p5@GNB2	p7@GNB2	p8@GNB2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	17.14	22.99	13.83	0.00	0.58	0.00	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	18.41	24.28	19.02	0.00	0.81	0.00	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	20.25	21.61	14.27	0.00	0.19	0.00	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	16.22	18.30	10.40	0.42	0.21	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	14.17	20.47	14.40	0.00	0.00	0.00	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	17.25	18.22	12.40	0.00	0.00	0.00	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	16.34	20.48	16.12	0.00	0.65	0.00	2.18
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	14.05	21.80	15.50	0.00	0.48	0.00	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	17.74	24.36	13.04	0.21	1.07	0.00	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	14.49	20.87	8.69	0.00	0.00	0.00	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	10.11	21.02	8.08	0.00	0.81	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	9.76	22.77	6.50	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	25.47	38.04	27.24	5.00	3.06	0.48	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	17.14	26.61	17.89	4.81	2.56	0.45	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	21.74	40.84	21.52	1.76	2.63	0.88	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	24.90	30.18	15.34	5.03	2.51	0.00	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	17.25	31.01	15.73	3.28	0.66	0.22	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	21.09	22.78	16.87	5.48	2.53	0.00	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	13.86	21.86	10.13	2.67	0.53	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	18.50	29.19	16.25	4.21	2.26	0.15	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	18.58	24.06	20.45	5.08	2.81	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	15.88	30.04	19.33	4.14	1.90	0.35	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	18.61	23.01	15.77	4.52	1.94	0.52	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	20.87	24.75	16.26	4.37	1.94	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	19.61	29.15	20.38	4.13	2.32	0.26	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	19.62	30.39	19.62	4.11	0.95	0.32	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	15.93	17.58	16.48	4.40	1.10	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	21.69	42.44	19.10	3.77	2.12	0.47	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	20.03	31.82	15.02	2.91	1.45	0.48	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	18.46	35.47	19.00	2.53	2.53	0.36	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	12.14	29.52	17.58	2.93	1.67	0.84	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	15.04	32.82	15.04	4.30	1.76	0.00	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	16.67	24.48	18.57	4.22	1.27	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	15.83	18.97	13.36	3.30	0.66	0.16	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	19.45	36.46	19.82	3.37	1.68	0.19	1.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	22.80	39.09	20.12	4.22	2.30	0.38	1.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	25.14	40.88	21.66	3.68	1.84	0.20	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	23.98	39.29	16.52	3.02	2.22	1.01	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	24.04	30.79	20.26	6.21	2.43	0.27	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	29.77	34.57	15.84	3.60	1.92	0.00	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	22.82	38.58	21.17	3.53	1.41	0.71	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	19.18	21.81	12.30	2.93	1.46	0.29	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	25.52	43.23	19.61	3.16	2.53	0.00	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	29.20	41.78	20.45	4.37	2.80	0.70	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	28.71	44.57	20.68	5.02	2.01	0.00	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	26.99	37.46	18.61	3.26	3.49	1.16	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	24.71	43.66	16.31	4.32	2.88	0.96	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	30.40	45.60	25.33	4.47	3.87	0.30	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	28.49	44.52	18.43	4.55	2.87	0.48	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	25.68	37.81	21.03	1.82	1.82	0.20	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	27.46	20.29	21.93	3.48	1.64	0.41	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	22.90	35.58	14.68	4.00	3.11	0.22	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	27.98	0.00	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	16.32	31.58	12.77	2.48	2.13	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	18.23	31.81	11.60	2.32	0.00	0.33	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	27.68	18.46	9.23	2.52	2.52	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	19.29	21.13	9.18	2.30	0.00	0.00	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	11.67	39.87	7.78	3.24	0.32	0.65	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	13.49	32.44	8.35	0.64	1.61	0.00	1.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	16.66	30.18	10.37	3.46	1.26	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	10.58	38.78	9.87	2.82	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	17.38	34.21	10.65	4.49	0.56	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	49.36	54.93	12.74	3.98	3.18	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	21.07	24.12	7.14	2.72	0.34	0.34	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	11.70	36.39	9.10	2.92	0.65	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	18.81	47.21	6.39	2.13	2.84	0.00	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	16.16	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	78.97	15.79	15.79	0.00	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	18.04	33.64	10.24	2.44	1.95	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	21.32	28.26	12.89	1.49	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	17.36	35.65	5.63	3.75	0.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	22.19	27.16	5.63	0.33	0.66	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	13.61	31.86	7.73	0.31	1.55	0.31	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	14.37	39.75	7.64	0.61	0.31	0.00	1.22
Adipocyte - breast, donor1	11376-118A8	26.45	16.79	15.20	1.11	2.06	0.32	1.90
Adipocyte - breast, donor2	11327-117E4	25.67	20.05	19.25	0.32	2.73	0.16	0.16
Adipocyte - omental, donor1	11473-119C6	19.47	14.25	13.10	1.91	1.78	0.00	1.15
Adipocyte - omental, donor2	11474-119C7	19.43	27.66	13.45	0.75	2.24	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	12.39	27.80	7.37	2.34	1.34	0.33	2.01
Adipocyte - perirenal, donor1	11476-119C9	26.80	33.81	10.21	1.91	1.28	0.00	2.55
Adipocyte - subcutaneous, donor1	11259-116F8	26.39	26.39	16.49	1.10	1.10	0.00	2.20
Adipocyte - subcutaneous, donor2	11336-117F4	25.74	14.45	7.68	1.35	2.26	0.00	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	29.89	32.84	14.60	0.52	3.13	0.00	1.56
Adipocyte differentiation, day04, donor1	13019-139D4	12.91	15.25	19.95	1.17	1.17	0.20	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	19.30	18.27	13.64	1.03	1.80	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	21.19	19.24	14.77	1.67	1.95	0.00	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	24.10	13.52	14.11	1.18	3.53	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	13.83	13.67	13.67	0.16	2.09	0.16	0.97
Adipocyte differentiation, day08, donor2	13023-139D8	20.01	18.40	17.75	0.97	0.97	0.00	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	14.93	14.40	12.80	1.60	1.60	0.00	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	21.70	14.47	13.35	0.00	1.11	0.56	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	18.30	19.55	9.98	0.83	0.42	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	23.36	13.31	13.06	0.00	1.76	0.00	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	14.40	14.40	13.09	0.33	1.64	0.00	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	17.66	16.75	8.53	0.30	1.52	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	30.06	24.53	21.22	5.08	1.99	2.21	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	58.45	89.65	34.42	12.91	5.38	5.02	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	32.35	19.17	34.74	8.39	5.99	1.20	2.40
Amniotic Epithelial Cells, donor1	11533-120A3	20.15	15.47	19.43	0.36	1.08	0.36	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	33.47	30.12	26.78	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	34.31	26.50	24.24	2.26	3.70	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	30.44	18.88	26.32	8.47	2.52	0.80	0.69
Anulus Pulposus Cell, donor2	11463-119B5	28.41	25.23	16.16	6.37	3.18	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	23.36	22.91	11.23	7.64	2.70	0.90	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	41.24	17.80	16.50	6.08	2.60	0.87	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	17.12	19.26	6.42	6.42	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	33.48	21.52	10.46	6.88	2.69	1.79	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	31.62	16.44	12.65	13.91	3.79	0.00	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	26.40	18.48	17.16	4.62	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	36.71	13.65	11.37	6.17	1.95	0.65	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	34.47	20.39	12.14	7.28	3.88	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	30.88	19.00	12.47	6.53	1.19	1.19	2.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	33.90	21.09	13.56	6.03	2.26	0.75	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	33.38	26.85	8.71	4.35	0.00	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	42.63	21.31	12.54	3.76	1.25	3.76	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	32.45	13.18	19.60	7.08	2.80	1.98	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	31.39	13.65	13.65	8.19	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	18.85	11.01	7.39	6.03	1.06	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	34.29	21.97	9.64	1.61	3.21	1.07	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	42.89	20.97	14.36	6.05	3.21	0.76	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	35.28	12.30	16.30	5.61	2.41	0.80	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	34.14	24.39	11.71	10.73	3.90	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	38.65	22.23	14.93	4.98	4.98	0.83	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	31.22	9.61	13.21	6.00	1.20	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	17.70	7.08	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	31.05	17.32	15.95	4.97	2.06	0.86	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	20.97	12.58	4.19	4.19	4.19	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	36.41	22.33	6.80	5.34	1.46	1.94	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	42.50	20.87	20.87	3.79	3.42	1.90	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	33.92	18.17	14.54	6.06	3.63	1.21	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	29.64	23.37	6.84	4.56	1.71	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	39.76	19.67	15.82	6.41	2.78	0.86	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	30.45	14.71	16.52	4.65	2.84	1.29	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	37.54	19.24	8.45	5.16	1.41	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	36.66	28.62	14.15	5.14	3.54	1.61	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	34.25	21.40	9.27	3.57	4.28	3.57	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	28.08	16.96	11.70	3.51	1.75	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	32.82	24.39	12.65	5.42	2.71	0.90	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	48.71	19.01	21.38	5.94	2.38	3.56	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	43.23	16.78	14.75	7.12	2.03	0.51	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	31.58	16.05	12.23	5.86	2.55	1.53	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	37.49	17.79	13.98	2.54	3.18	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	28.91	20.28	12.51	6.47	2.16	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	34.50	20.75	12.70	5.50	2.96	2.12	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	34.51	16.53	13.63	6.09	2.61	1.16	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	24.56	14.17	15.12	3.78	3.78	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	36.79	22.89	13.05	5.76	4.75	0.85	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	34.75	25.48	13.90	4.63	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	14.79	23.24	10.56	4.23	4.23	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	33.23	28.30	10.72	4.93	2.57	0.43	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	32.49	16.24	15.64	7.22	2.41	1.80	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	38.64	22.60	13.12	5.10	2.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	46.90	21.38	15.63	5.75	2.30	1.61	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	35.70	22.95	5.10	7.65	2.55	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	16.02	11.69	7.63	3.81	1.78	1.02	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	37.98	20.23	17.55	7.23	3.72	0.41	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	32.74	15.91	13.77	4.90	3.06	1.53	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	43.02	23.90	13.86	6.21	2.39	0.96	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	33.26	21.51	14.19	5.32	3.33	0.89	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	30.52	13.73	6.10	4.58	1.53	1.53	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	35.45	17.72	9.97	3.88	3.88	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	31.51	23.83	12.71	4.50	1.59	1.06	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	35.25	18.90	6.91	6.54	3.27	0.73	0.00
Astrocyte - cerebellum, donor1	11500-119F6	22.97	25.05	21.74	4.18	0.98	1.23	0.12
Astrocyte - cerebellum, donor2	11580-120F5	28.07	64.18	22.42	10.95	2.05	1.20	0.68
Astrocyte - cerebellum, donor3	11661-122F5	26.01	33.14	43.84	6.71	2.31	1.47	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	32.07	28.24	32.42	13.59	1.74	1.39	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	47.08	43.36	35.91	15.37	4.04	4.21	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	35.35	43.41	43.41	10.59	2.09	1.94	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	23.51	26.03	15.25	0.92	1.61	0.34	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	24.30	21.42	15.28	0.50	2.51	0.13	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	26.74	21.96	14.34	0.57	1.71	0.00	0.11
Basophils, donor1	12241-129G9	44.46	25.37	23.54	3.40	2.62	2.62	1.05
Basophils, donor2	12242-129H1	16.24	13.71	17.68	7.22	0.00	2.16	0.36
Basophils, donor3	12243-129H2	32.05	21.61	28.37	2.94	2.20	2.06	0.88
Bronchial Epithelial Cell, donor1	11511-119G8	25.44	14.01	21.78	1.51	2.16	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	55.32	69.49	34.75	2.29	3.66	0.91	2.29
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	43.04	28.69	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	57.74	55.86	23.85	5.65	1.88	1.26	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	58.23	62.18	35.14	8.53	4.57	2.08	1.87
Bronchial Epithelial Cell, donor6	11461-119B3	28.56	39.38	26.25	5.76	0.92	1.84	1.38
Bronchial Epithelial Cell, donor7	11769-123I5	23.57	25.91	21.05	2.16	1.08	0.36	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	13.91	10.92	30.81	1.65	1.55	0.10	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	11.18	13.04	21.66	0.00	0.47	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	23.02	17.91	10.23	1.60	0.96	0.96	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	10.34	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	38.89	18.60	17.47	1.69	4.51	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	46.59	29.70	28.77	3.53	2.78	2.04	0.56
CD14+ Monocytes, donor3	11381-118B4	41.27	26.56	36.88	4.39	2.41	1.98	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	29.44	10.47	16.13	0.28	3.40	0.00	6.23
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	26.16	16.30	14.78	0.00	2.27	0.00	4.55
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	34.19	21.37	22.35	0.00	3.94	0.33	1.64
CD14+ monocytes - mock treated, donor1	11863-125A9	64.90	32.23	29.63	2.75	5.78	2.31	3.61
CD14+ monocytes - mock treated, donor2	11873-125C1	41.34	21.42	17.80	0.91	1.81	1.81	2.11
CD14+ monocytes - mock treated, donor3	11883-125D2	56.62	23.22	34.59	3.55	3.32	1.42	4.03
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	53.57	23.94	19.75	2.34	3.52	2.34	2.01
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	41.40	17.94	11.87	0.55	1.93	0.83	1.38
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	39.42	18.35	22.31	1.74	2.73	1.74	1.49
CD14+ monocytes - treated with BCG, donor1	11860-125A6	42.68	18.01	20.17	2.55	2.94	0.98	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	44.33	19.23	13.00	2.49	2.31	1.07	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	35.69	16.10	19.37	2.39	1.74	1.52	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	27.86	11.71	18.96	2.11	0.94	3.28	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	32.21	13.73	14.78	2.64	1.06	2.64	2.11
CD14+ monocytes - treated with Candida, donor3	11888-125D7	27.73	17.75	23.30	3.33	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	46.11	23.65	24.54	3.87	4.61	1.93	3.42
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	43.70	20.35	14.37	2.00	1.80	1.80	2.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	30.40	11.03	18.74	2.50	2.08	2.71	1.25
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	58.11	28.60	23.11	3.20	3.66	1.60	2.97
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	29.63	8.37	9.05	1.81	1.13	1.81	2.04
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	34.48	17.02	17.89	6.11	1.75	1.75	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	51.11	25.02	21.52	1.61	4.03	1.61	1.88
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	39.78	20.06	21.81	4.19	2.44	2.27	2.79
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	57.23	21.46	31.14	2.95	2.52	0.84	3.37
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	42.25	16.35	14.51	2.20	2.20	1.29	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	27.83	13.03	8.45	2.11	2.47	0.70	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	41.68	15.79	15.36	2.63	2.19	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	40.80	18.83	22.32	1.39	2.27	1.74	1.05
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	31.96	18.21	16.35	1.12	1.86	1.49	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	35.13	10.56	22.85	2.16	0.86	1.29	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	36.03	14.33	17.61	2.46	2.87	1.23	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	25.50	7.19	8.11	2.09	0.46	1.16	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	18.33	6.50	11.14	1.86	0.93	1.39	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	51.88	15.04	21.58	2.40	5.23	1.31	1.96
CD14+CD16+ Monocytes, donor2	11801-124D1	89.63	18.48	24.72	3.70	4.16	1.62	3.23
CD14+CD16+ Monocytes, donor3	11912-125G4	64.55	15.60	21.44	1.95	2.60	0.43	1.52
CD14+CD16- Monocytes, donor1	11788-124B6	67.12	26.01	33.79	3.58	4.83	2.02	1.09
CD14+CD16- Monocytes, donor2	11799-124C8	59.03	15.54	20.26	1.05	1.75	1.22	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	45.71	17.39	28.99	1.78	1.78	0.89	1.34
CD14-CD16+ Monocytes, donor1	11790-124B8	96.46	22.46	28.07	6.38	4.08	2.81	1.79
CD14-CD16+ Monocytes, donor2	11800-124C9	101.66	20.64	25.03	7.47	5.71	3.29	2.85
CD14-CD16+ Monocytes, donor3	11911-125G3	72.01	21.69	28.84	5.05	5.26	2.11	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	34.55	20.32	20.32	4.06	6.10	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	45.42	29.15	12.20	1.36	2.71	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	32.10	23.82	16.57	10.36	0.00	0.00	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	41.58	11.19	21.32	5.86	1.07	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	46.10	28.41	21.44	9.65	2.68	0.54	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	29.48	14.74	11.23	3.51	1.40	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	40.79	23.53	11.77	0.78	3.14	0.00	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	31.64	30.32	11.86	2.64	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	9.86	18.08	14.79	9.04	0.82	2.47	0.82
CD19+ B Cells, donor2	11624-122B4	10.16	13.78	13.78	3.63	0.00	1.45	0.73
CD19+ B Cells, donor3	11705-123B4	14.64	16.66	14.14	6.56	1.51	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	46.87	18.18	44.45	0.00	2.02	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	32.76	17.58	46.34	0.00	4.79	0.00	1.20
CD34+ Progenitors, donor1	11545-120B6	10.04	6.02	13.05	1.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	15.17	10.11	6.18	3.93	0.00	4.49	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	19.92	19.16	16.16	0.38	2.25	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	24.13	12.40	13.98	1.58	2.25	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	11.43	6.78	21.42	5.36	0.36	0.71	0.00
CD4+ T Cells, donor2	11306-117C1	23.27	11.63	20.82	12.86	1.84	1.84	0.61
CD4+ T Cells, donor3	11382-118B5	22.57	13.72	23.48	6.71	1.52	2.13	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	26.80	13.27	14.55	16.59	2.04	3.57	1.28
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	39.75	13.03	19.76	13.93	1.57	0.45	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	44.84	14.95	26.73	15.81	1.72	1.44	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	25.60	11.38	17.07	20.86	2.37	2.84	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	30.20	8.43	22.47	17.56	1.40	2.11	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	19.78	13.18	42.85	19.78	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	22.83	11.13	17.92	12.43	1.16	0.87	0.87
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	52.70	19.49	30.33	11.35	2.20	1.02	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	38.69	18.22	36.27	10.16	1.93	1.13	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	41.69	11.66	26.45	11.21	3.59	2.24	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	42.97	12.93	30.05	11.88	2.10	1.75	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	25.96	10.56	18.92	5.72	2.20	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	18.13	10.12	12.65	13.91	1.26	0.84	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	36.78	18.08	19.53	4.78	1.25	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	36.42	16.04	24.06	11.03	1.67	1.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	20.12	7.07	21.75	19.04	0.82	0.54	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	17.69	4.82	11.79	15.01	0.54	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	16.14	10.76	28.69	7.17	0.00	1.79	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	33.19	11.87	21.32	12.42	2.23	2.78	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	35.31	8.45	20.36	9.31	2.82	0.22	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	34.04	16.81	27.95	7.36	1.05	0.63	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	30.84	13.15	16.68	13.15	1.01	1.01	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	37.26	10.40	27.29	8.67	3.03	1.30	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	24.41	10.90	22.66	5.67	0.44	0.87	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	43.05	16.83	22.27	10.39	3.96	0.00	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	30.47	16.62	14.77	5.54	0.00	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	34.90	11.17	11.17	12.56	2.79	1.40	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	34.34	19.11	18.55	11.35	1.94	0.28	1.66
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	24.05	14.48	12.51	6.38	0.98	0.98	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	18.48	13.86	16.94	4.62	1.54	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	47.27	14.32	24.35	7.16	2.86	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	47.09	23.54	18.00	19.39	5.54	1.38	2.77
CD8+ T Cells, donor1	11226-116C2	14.73	8.51	16.37	10.80	0.98	1.64	0.33
CD8+ T Cells, donor2	11307-117C2	19.15	16.89	22.15	10.14	0.00	1.88	0.38
CD8+ T Cells, donor3	11383-118B6	12.62	14.39	25.50	17.93	1.77	2.52	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	40.37	20.87	13.08	2.52	2.98	1.61	1.38
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	39.30	19.89	11.50	3.83	2.40	1.92	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	32.56	16.42	12.86	3.56	1.37	3.01	1.37
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	28.82	12.61	7.81	3.60	1.50	1.20	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	28.80	17.52	13.92	3.60	0.72	3.36	1.68
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	31.83	19.33	8.41	2.96	1.36	2.73	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	40.63	18.69	16.08	2.82	2.17	2.17	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	48.69	23.95	12.63	2.37	3.16	1.84	1.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	39.16	19.46	11.26	2.81	1.64	2.81	2.11
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	41.66	16.91	18.72	3.62	3.92	1.81	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	45.90	21.50	13.07	2.91	2.32	1.74	1.45
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	41.30	16.79	17.85	2.66	1.87	4.00	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	34.58	9.19	10.07	3.06	1.31	3.06	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	32.34	15.03	11.84	2.73	1.82	5.01	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	24.61	11.93	8.95	2.24	1.49	2.24	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	29.53	18.37	12.61	3.24	1.80	2.52	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	24.74	16.69	11.22	4.03	2.30	3.16	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	21.45	11.31	9.90	2.83	0.94	2.59	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	32.64	15.85	11.73	2.54	1.27	3.80	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	31.68	16.30	15.99	3.69	1.23	1.85	1.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	27.89	18.91	9.30	2.24	1.60	2.56	1.28
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	31.74	17.21	14.92	2.29	1.53	2.68	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	32.71	12.61	16.95	3.55	2.76	2.76	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	26.47	21.18	13.62	1.51	1.51	5.29	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	39.34	19.27	12.04	8.03	1.61	7.23	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	30.77	16.79	16.09	3.50	0.70	3.50	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	34.06	19.03	20.04	2.00	1.00	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	78.59	3.66	31.07	5.48	7.31	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	37.06	25.69	22.23	7.41	0.99	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	26.52	21.05	25.26	3.89	3.16	0.63	0.21
Chondrocyte - de diff, donor1	11261-116G1	23.23	24.27	9.36	3.47	1.73	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	29.14	16.35	18.12	3.55	2.84	0.36	3.91
Chondrocyte - de diff, donor3	11410-118E6	33.68	23.89	27.65	7.51	3.98	0.34	1.93
Chondrocyte - re diff, donor2	11339-117F7	12.53	9.85	9.85	0.00	3.58	0.90	1.79
Chondrocyte - re diff, donor3	11411-118E7	32.35	19.41	22.24	4.04	2.43	0.00	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	18.13	17.90	14.46	7.00	1.03	2.52	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	32.06	29.07	26.72	7.70	2.14	1.92	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	26.99	31.86	25.49	6.46	3.01	2.39	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	17.97	13.30	27.51	0.92	1.19	0.37	1.56
Corneal Epithelial Cells, donor1	11526-119I5	29.20	16.91	20.64	3.29	2.63	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	26.16	14.79	23.89	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	34.25	34.00	29.14	5.62	2.30	1.53	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	36.65	14.53	12.55	0.33	2.97	0.17	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	44.16	13.88	10.41	0.00	2.84	0.32	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	31.06	13.80	10.35	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	38.23	21.60	8.64	0.11	3.46	0.00	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	17.77	10.25	30.06	2.05	1.37	0.34	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	23.50	12.40	19.59	3.26	1.31	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	16.94	8.71	10.16	1.94	0.00	0.97	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	38.52	17.51	21.85	3.67	2.67	1.33	0.83
Endothelial Cells - Aortic, donor1	11263-116G3	43.42	29.34	17.02	2.93	4.11	1.17	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	45.25	21.21	22.62	4.24	2.26	1.98	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	49.93	21.63	32.24	6.29	6.68	3.93	0.79
Endothelial Cells - Artery, donor1	11264-116G4	68.06	44.21	27.63	4.94	5.53	1.75	1.16
Endothelial Cells - Artery, donor2	11341-117F9	64.70	35.53	34.82	10.82	4.71	2.59	0.94
Endothelial Cells - Artery, donor3	11413-118E9	53.82	31.91	28.22	8.41	3.16	1.93	1.05
Endothelial Cells - Lymphatic, donor1	11236-116D3	26.60	13.96	17.73	2.44	1.33	1.11	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	21.30	16.13	11.56	2.43	2.74	0.61	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	16.07	11.28	7.33	1.69	1.41	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	25.85	16.34	22.58	3.86	0.59	1.49	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	27.60	10.93	19.26	5.21	0.52	1.04	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	46.93	23.54	33.18	3.97	5.53	0.57	0.57
Endothelial Cells - Thoracic, donor1	11266-116G6	35.61	18.01	12.40	2.40	2.00	1.60	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	78.62	33.02	34.59	7.86	6.81	3.67	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	29.07	16.03	21.87	4.85	1.86	1.62	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	28.03	33.24	22.81	2.82	1.74	1.52	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	28.94	30.29	24.55	5.74	2.32	0.73	0.24
Endothelial Cells - Vein, donor1	11267-116G7	75.08	46.64	44.36	10.24	11.38	1.14	1.14
Endothelial Cells - Vein, donor2	11344-117G3	53.78	27.94	31.43	6.29	2.10	4.19	1.40
Endothelial Cells - Vein, donor3	11416-118F3	55.42	42.86	46.00	6.75	6.59	1.26	1.26
Eosinophils, donor1	12244-129H3	30.49	15.25	15.25	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	186.48	151.82	62.71	31.35	4.95	16.50	1.65
Eosinophils, donor3	12246-129H5	164.07	149.81	89.17	17.83	21.40	28.53	7.13
Esophageal Epithelial Cells, donor1	11507-119G4	20.52	15.88	18.81	1.22	2.69	0.24	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	33.28	12.48	0.00	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	32.54	32.54	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	17.65	27.50	13.96	3.28	0.82	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	24.53	25.62	9.85	3.83	3.18	0.55	4.49
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	39.65	42.58	20.69	4.01	3.68	0.33	5.20
Fibroblast - Aortic Adventitial, donor1	11245-116E3	30.44	21.22	20.01	4.61	3.15	0.24	3.88
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	19.79	9.28	7.64	1.77	1.64	0.68	0.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	30.06	28.79	17.09	4.85	4.22	0.32	3.90
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	19.76	10.54	7.11	1.05	1.32	0.00	1.84
Fibroblast - Aortic Adventitial, donor3	11401-118D6	43.52	34.55	27.24	4.32	3.32	0.33	4.65
Fibroblast - Cardiac, donor1	11268-116G8	60.33	36.74	20.87	8.17	3.18	1.81	0.91
Fibroblast - Cardiac, donor2	11345-117G4	55.33	30.32	34.11	6.06	2.27	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	41.32	29.02	33.28	7.25	5.36	1.10	0.95
Fibroblast - Cardiac, donor4	11452-119A3	17.58	12.12	9.40	2.12	1.52	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	27.41	27.92	18.15	2.66	2.66	0.25	0.76
Fibroblast - Cardiac, donor6	11460-119B2	36.08	36.38	15.77	1.67	2.88	0.30	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	19.16	17.95	10.85	2.28	1.21	0.40	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	30.63	25.45	13.81	3.88	4.31	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	48.34	35.16	20.51	4.39	4.39	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	24.22	22.83	23.29	7.84	2.77	1.38	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	35.62	14.08	22.56	8.14	2.37	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	25.36	26.53	11.97	5.63	3.05	0.23	1.41
Fibroblast - Dermal, donor2	11346-117G5	34.90	18.87	23.58	5.19	4.72	0.94	0.47
Fibroblast - Dermal, donor3	11418-118F5	27.32	23.09	18.98	2.54	2.30	0.60	0.48
Fibroblast - Dermal, donor4	11450-119A1	28.04	34.48	17.07	3.62	2.26	0.57	0.57
Fibroblast - Dermal, donor5	11454-119A5	30.53	28.26	17.27	2.62	2.79	1.22	0.35
Fibroblast - Dermal, donor6	11458-119A9	27.12	35.90	16.73	4.87	2.27	0.49	0.49
Fibroblast - Gingival, donor1	11237-116D4	25.40	14.99	16.87	4.58	1.46	1.04	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	34.32	24.37	17.82	3.67	2.36	0.00	2.62
Fibroblast - Gingival, donor2	11318-117D4	28.60	36.37	14.23	8.70	3.29	1.19	0.40
Fibroblast - Gingival, donor3	11394-118C8	35.58	32.29	19.82	7.83	2.51	0.48	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	33.24	19.74	17.66	4.16	4.16	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	43.87	30.84	24.84	5.81	3.00	0.53	3.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	46.92	29.00	27.13	4.52	2.49	0.47	1.71
Fibroblast - Gingival, donor6 (control)	11922-125H5	30.02	17.58	19.20	4.60	2.43	0.54	3.11
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	71.63	48.70	21.53	2.47	4.23	0.71	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	27.79	23.98	16.23	3.22	2.78	0.73	1.75
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	29.59	13.23	13.77	2.45	1.91	0.14	1.50
Fibroblast - Gingival, donor8 (control)	11926-125H9	36.31	26.22	18.98	2.41	1.97	0.22	1.97
Fibroblast - Gingival, donor9 (control)	11927-125I1	36.24	27.29	21.57	6.46	1.47	0.44	4.40
Fibroblast - Lung, donor1	11270-116H1	61.17	28.55	21.75	6.80	2.72	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	19.40	19.40	5.97	2.98	0.00	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	53.60	36.93	38.41	11.18	4.01	1.69	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	14.99	14.16	18.33	2.50	1.67	1.67	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	18.18	33.57	9.79	6.99	5.59	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	24.63	31.07	26.59	5.04	2.80	0.28	0.28
Fibroblast - Mammary, donor1	11540-120B1	22.33	13.80	21.11	2.44	1.62	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	35.95	35.95	31.95	11.98	0.00	3.99	3.99
Fibroblast - Mammary, donor3	11701-123A9	0.00	11.91	29.78	5.96	11.91	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	36.47	17.26	26.19	9.31	2.13	0.78	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	41.56	34.74	25.33	6.22	3.79	0.76	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	26.01	12.55	13.16	2.14	2.14	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	36.25	29.77	16.79	3.05	4.96	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	54.81	25.11	35.10	3.24	5.67	0.54	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	33.75	28.30	24.24	3.36	3.60	0.70	1.74
Fibroblast - Pulmonary Artery, donor1	11250-116E8	42.00	22.77	19.90	4.97	3.87	0.88	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	23.37	17.68	13.82	1.63	1.63	0.61	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	34.75	31.41	24.72	6.01	3.34	0.67	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	36.77	22.54	28.86	9.88	1.19	1.58	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	20.04	10.32	5.36	0.79	1.19	0.20	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	20.96	8.88	11.19	1.95	1.24	0.18	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	21.29	10.84	8.67	1.38	1.77	0.39	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	21.66	12.64	16.55	0.60	0.90	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	19.86	14.68	10.04	1.08	1.51	0.11	0.97
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	24.04	11.14	7.09	1.01	0.76	0.76	0.00
Fibroblast - skin normal, donor1	11553-120C5	22.97	14.77	12.47	0.82	2.13	0.00	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	21.25	7.22	9.62	0.00	1.00	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	22.30	21.90	9.85	1.11	1.21	0.30	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	22.97	12.39	9.97	0.30	2.72	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	22.53	11.43	17.48	1.91	1.74	0.25	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	21.20	19.66	5.30	2.22	1.71	0.17	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	22.33	13.14	5.58	0.99	1.64	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	30.36	22.05	10.44	1.81	1.70	0.11	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	27.33	17.88	32.56	3.04	1.69	0.34	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	34.03	31.05	10.66	1.25	0.94	0.00	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	0.00	0.00	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	21.79	13.07	19.17	0.00	0.87	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	43.69	14.39	14.74	0.52	2.43	0.69	2.08
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	32.79	14.05	16.92	2.08	2.08	1.04	1.30
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	37.05	18.91	15.33	0.77	3.58	0.26	1.79
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	21.44	33.68	33.68	12.25	1.53	4.59	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	29.35	27.44	26.16	10.21	0.64	6.38	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	17.40	35.37	11.98	6.85	0.86	1.14	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	5.52	24.54	37.23	11.58	1.10	3.31	2.48
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	16.90	26.71	36.53	2.97	0.91	1.60	2.97
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	18.43	54.29	21.79	6.74	1.98	2.38	2.18
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	12.16	25.11	39.65	7.14	0.53	4.76	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	10.11	32.61	30.66	6.85	0.33	1.63	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	9.29	23.88	15.04	3.98	1.33	2.65	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	21.48	21.62	24.31	6.78	1.27	3.25	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	25.00	29.43	26.97	4.19	0.86	2.22	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	17.46	17.46	19.61	6.18	1.88	2.69	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	31.47	37.91	34.07	6.07	2.11	3.22	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	26.99	32.39	29.07	6.09	1.11	3.74	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	22.16	22.36	19.92	7.12	0.81	4.27	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	31.03	44.27	31.26	4.34	3.19	2.28	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	28.65	39.99	30.14	3.74	1.37	1.87	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	26.23	40.22	25.14	4.15	2.19	1.53	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	38.41	48.75	43.14	2.95	2.36	0.89	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	29.73	34.02	30.36	2.07	0.79	0.79	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	21.90	35.52	30.16	2.23	4.02	0.45	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	40.33	35.89	38.31	2.02	2.42	1.81	1.61
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	31.21	35.46	37.49	3.22	0.85	0.51	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	20.66	17.20	28.64	2.39	1.77	0.71	0.98
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	22.48	23.31	39.44	1.87	1.56	0.21	1.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	20.32	23.23	33.47	1.20	2.05	0.17	1.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	32.53	34.19	36.74	2.21	0.89	0.55	0.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	22.46	18.55	30.28	2.41	2.33	1.00	1.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	17.76	15.52	27.77	2.25	0.41	0.20	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	30.95	40.23	50.34	1.86	1.24	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	33.67	33.55	43.47	1.50	1.38	0.35	0.69
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	33.19	32.85	42.69	1.83	1.67	0.83	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	31.30	38.35	43.87	1.76	1.32	0.22	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	36.90	37.76	38.13	1.60	0.86	0.98	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	27.23	34.69	32.90	2.43	1.46	0.49	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	23.41	42.33	40.41	1.28	0.96	0.00	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	38.09	35.06	38.85	0.38	1.33	0.38	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	28.63	28.47	34.64	0.63	1.27	0.00	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	21.59	40.44	34.97	0.61	2.13	0.91	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	40.14	36.69	38.57	1.67	2.30	0.31	1.15
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	30.52	28.98	36.23	1.54	1.98	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	31.42	29.46	34.51	1.96	1.96	0.56	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	31.29	28.52	32.50	1.30	1.39	0.28	1.02
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	25.94	26.21	36.37	0.80	1.87	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	30.30	24.94	34.58	0.77	3.37	0.77	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	37.31	34.33	28.37	0.52	1.55	0.13	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	24.13	29.00	27.38	0.81	2.71	0.27	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	33.00	31.52	30.79	0.74	2.21	0.37	1.11
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	37.50	27.19	38.16	0.44	2.63	0.22	1.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	24.79	38.68	19.83	0.00	2.98	0.00	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	34.03	21.77	34.56	0.79	2.77	0.40	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	38.13	30.67	30.67	1.61	2.82	0.20	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	15.00	10.42	20.84	0.25	0.25	0.00	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	10.35	15.92	10.35	5.77	0.20	2.39	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	17.10	23.11	18.03	5.24	0.77	2.00	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	16.37	19.03	22.50	3.07	1.43	1.84	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	15.96	25.97	18.15	4.07	1.25	2.19	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	13.56	15.54	24.30	3.96	1.13	2.26	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	4.15	9.69	20.29	3.23	0.00	2.77	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	24.75	34.65	17.32	4.95	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	17.79	25.14	23.98	4.64	2.71	4.25	2.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	11.23	24.07	22.46	3.21	1.60	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	12.17	13.91	31.30	8.69	0.00	3.48	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	8.46	19.53	26.69	4.88	0.98	2.28	1.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	14.00	18.12	19.77	4.12	1.65	0.82	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	10.00	43.32	33.32	6.66	6.66	0.00	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	14.54	23.49	24.61	5.03	0.00	1.40	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	15.69	23.86	29.74	3.27	0.65	0.00	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	19.29	21.81	18.45	4.19	0.84	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	16.86	21.95	26.08	1.27	1.27	1.27	3.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	20.38	23.10	27.51	2.72	1.02	0.00	2.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	10.44	33.41	31.32	2.09	2.09	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	15.46	29.78	45.82	3.44	1.15	2.29	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	19.53	26.05	32.26	3.55	1.18	0.89	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	22.02	33.88	35.58	6.78	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	21.95	31.07	30.65	4.14	2.49	1.24	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	18.41	21.86	27.62	2.76	0.92	1.84	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	26.34	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	11.92	22.30	26.91	1.54	0.38	0.77	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	12.71	24.45	23.14	3.26	1.96	1.30	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	21.40	47.49	36.12	5.35	2.68	0.67	3.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	18.49	20.80	35.83	2.70	2.31	0.39	2.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	19.17	20.54	33.21	1.71	0.68	1.03	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	24.85	42.24	22.36	4.97	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	21.71	34.92	36.80	5.19	0.94	0.47	2.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	24.74	29.57	35.00	4.22	3.62	0.60	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	17.29	47.31	45.27	0.51	4.07	1.02	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	19.14	24.73	31.91	2.39	0.40	0.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	21.21	31.08	35.52	2.96	0.00	0.00	1.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	12.98	25.97	29.51	3.54	0.00	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	17.50	32.67	32.67	2.33	0.58	1.17	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	21.07	33.79	30.28	3.51	1.32	0.88	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	12.72	25.43	27.97	1.70	0.00	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	14.92	10.74	30.44	1.79	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	17.47	23.78	28.14	3.40	0.49	0.49	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	42.23	28.53	17.12	2.28	4.57	1.14	4.57
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	53.22	34.10	29.52	2.91	4.57	0.83	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	93.33	29.24	29.24	4.50	7.87	0.00	4.50
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	35.52	20.62	20.93	4.12	2.54	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	28.82	20.89	11.28	10.03	2.92	0.42	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	24.02	14.85	11.60	0.00	1.51	0.00	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	25.66	13.84	11.65	0.00	1.18	0.00	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	19.79	10.01	9.10	0.00	0.91	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	22.41	16.72	12.24	0.00	1.09	0.11	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	22.14	14.40	9.89	0.00	2.36	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	18.30	11.41	8.18	0.00	1.08	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	25.78	15.69	14.94	0.25	1.74	0.00	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	23.67	12.87	8.92	0.00	1.54	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	24.99	10.89	9.61	0.00	2.88	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	26.86	40.85	21.83	1.68	2.80	0.00	2.24
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	41.55	37.22	25.53	2.16	1.30	0.87	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	29.08	2.64	21.15	2.64	2.64	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	30.33	21.87	19.40	5.29	5.29	2.12	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	33.42	30.51	31.24	4.36	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	43.88	28.67	24.30	5.77	4.55	1.05	0.52
Hepatocyte, donor1	11523-119I2	27.84	18.16	12.11	1.21	2.42	0.00	0.00
Hepatocyte, donor2	11603-120I1	60.33	29.09	22.62	0.00	3.23	1.08	0.00
Hepatocyte, donor3	11684-122I1	52.15	25.77	14.72	0.00	2.45	0.00	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	20.23	8.48	33.29	1.96	0.00	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	21.50	11.89	13.46	0.00	1.75	0.00	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	20.31	15.92	10.98	3.02	3.02	1.51	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	79.60	50.94	41.39	3.18	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	46.73	33.38	33.38	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	66.45	44.30	26.30	1.38	5.54	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	35.04	25.03	20.02	0.00	0.00	0.00	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	35.60	59.34	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	71.76	33.32	38.44	0.00	5.13	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	54.85	18.28	22.85	0.00	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	47.11	27.61	40.61	1.62	4.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	45.02	35.01	35.01	1.67	1.67	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	21.78	25.41	25.41	0.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	78.08	35.73	37.06	2.65	1.32	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	59.87	64.30	38.80	0.00	1.11	0.00	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	57.62	20.95	41.91	0.00	10.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	66.77	29.60	39.05	1.26	3.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	66.50	41.76	27.84	0.00	4.64	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	29.27	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	69.77	29.07	30.36	0.00	5.17	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	91.77	43.47	37.03	0.00	3.22	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	83.64	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	57.04	37.48	36.67	0.81	4.89	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	60.03	29.39	49.12	0.00	3.78	0.00	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	71.86	28.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	68.31	33.75	27.33	1.61	0.80	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	70.17	39.70	24.01	0.00	4.62	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	75.40	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	61.84	43.43	24.55	0.94	1.42	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	68.93	38.09	33.56	0.00	3.63	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	88.45	0.00	0.00	14.74	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	72.10	43.04	32.28	1.08	5.38	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	94.01	74.96	36.84	1.27	3.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	16.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	47.19	37.62	31.88	0.64	0.64	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	78.37	47.39	27.34	0.00	0.00	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	63.22	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	66.41	44.99	31.42	0.00	2.14	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	66.37	46.46	19.91	0.00	0.00	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	83.39	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	64.20	28.09	28.40	1.54	1.23	0.31	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	61.46	63.22	26.34	3.51	8.78	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	40.86	34.57	9.43	0.00	6.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	59.80	36.86	26.42	0.00	4.17	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	84.10	53.11	44.26	2.21	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	81.05	58.36	25.94	3.24	3.24	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	77.60	34.88	34.88	0.87	2.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	92.24	40.50	33.75	0.00	4.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	90.60	31.36	13.94	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	64.01	51.21	49.07	0.00	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	59.57	41.56	29.09	1.39	2.77	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	76.94	45.59	19.95	0.00	8.55	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	73.63	33.14	47.86	0.00	1.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	57.48	75.63	54.46	0.00	6.05	3.03	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	55.88	49.67	31.04	0.00	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	67.67	48.64	48.64	0.00	5.29	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	24.97	10.77	13.22	2.04	1.71	0.41	0.65
Keratinocyte - epidermal, donor2	11349-117G8	39.82	14.64	24.60	1.76	1.76	1.76	0.00
Keratinocyte - epidermal, donor3	11421-118F8	28.78	18.74	26.50	3.88	2.18	0.57	0.38
Keratinocyte - oral, donor1	11251-116E9	30.54	18.16	33.15	3.52	1.70	0.34	0.11
Keratocytes, donor1	11527-119I6	26.82	26.48	28.88	6.88	2.75	0.34	0.34
Keratocytes, donor2	11607-120I5	44.53	22.26	16.41	11.72	2.34	2.34	0.00
Keratocytes, donor3	11688-122I5	35.17	29.44	19.36	4.35	2.96	0.40	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	48.35	63.74	19.78	0.00	4.40	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	25.89	38.83	14.02	2.16	0.00	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	23.41	16.61	26.30	5.19	1.15	1.61	0.00
Lens Epithelial Cells, donor3	11690-122I7	18.26	12.92	9.18	4.74	1.82	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	35.22	14.47	20.40	3.08	3.08	0.71	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	25.67	12.28	22.05	1.40	1.67	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	24.40	11.18	24.40	2.99	2.99	1.10	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	29.57	11.29	15.59	2.15	1.08	1.61	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	30.26	12.92	21.43	1.58	0.95	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	29.11	13.37	26.41	2.48	1.73	1.08	0.65
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	32.42	9.03	23.39	2.46	1.23	1.64	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	29.33	12.89	29.07	2.02	2.28	0.25	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	28.57	11.54	25.05	3.10	2.39	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	23.73	7.12	22.55	1.98	1.19	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	14.35	11.44	18.81	3.30	2.52	0.78	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	30.18	11.29	30.92	4.07	2.22	0.74	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	27.87	6.97	17.77	2.09	2.44	0.35	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	25.52	12.40	16.94	4.05	2.39	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	29.39	10.85	28.98	3.02	2.47	1.24	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	27.10	10.16	23.10	2.46	2.16	0.31	1.54
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	23.69	12.47	24.94	1.87	1.56	1.25	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	38.79	13.72	26.35	3.11	3.11	1.28	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	30.28	13.82	19.75	2.30	2.63	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	23.14	13.47	24.60	2.05	0.59	1.17	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	30.12	13.69	30.12	3.73	1.49	1.24	1.99
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	28.13	7.76	14.55	0.97	2.91	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	13.46	10.23	19.66	3.50	1.08	1.08	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	24.37	12.56	28.31	2.88	1.82	0.91	0.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	22.81	7.78	19.18	1.56	1.04	0.52	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	16.96	9.84	15.29	3.77	1.47	0.84	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	31.88	11.13	26.16	3.61	2.86	0.45	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	31.64	10.32	11.69	0.00	3.44	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	21.07	11.29	17.87	2.07	2.07	0.75	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	29.16	12.19	31.91	2.86	2.65	1.17	0.74
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	24.71	12.11	19.87	1.45	2.91	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	13.89	6.62	20.18	1.98	2.32	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	30.35	13.01	28.12	3.47	2.48	1.12	1.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	31.84	10.00	21.47	3.33	2.59	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	14.33	8.89	21.00	2.22	2.47	0.99	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	23.65	11.14	30.94	4.54	1.65	0.82	0.82
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	28.63	10.61	21.23	3.22	2.57	0.32	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	18.26	4.56	20.69	2.74	1.22	0.00	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	25.61	13.72	26.87	2.52	2.94	1.26	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	29.16	11.73	22.04	2.49	3.20	0.00	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	17.94	7.76	16.97	3.88	0.97	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	28.01	11.83	26.14	4.67	2.96	2.18	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	25.07	12.18	18.98	1.79	2.51	0.72	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	25.48	10.13	19.27	2.61	1.63	0.33	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	32.72	9.89	30.61	4.00	3.30	1.41	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	33.54	11.26	15.22	2.35	1.98	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	18.19	9.48	22.03	3.07	2.05	0.51	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	26.85	12.53	23.27	1.49	2.39	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	65.71	45.32	40.79	6.80	9.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	100.49	92.82	52.17	1.53	9.21	0.00	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	77.93	63.09	31.17	1.48	8.16	2.23	1.48
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	77.86	52.47	52.04	4.65	4.65	1.27	3.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	108.31	99.87	44.31	7.74	8.44	0.70	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	84.99	70.05	42.03	5.60	8.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	75.23	59.77	41.74	4.64	5.67	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	99.91	102.29	67.80	1.19	8.33	0.00	3.57
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	100.20	56.32	52.93	5.65	6.56	0.90	1.36
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	71.25	52.64	42.75	4.07	4.94	2.33	2.62
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	94.54	72.93	43.22	3.60	9.45	1.80	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	88.34	49.05	49.05	6.23	6.50	1.49	1.90
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	92.95	62.65	51.35	7.70	3.59	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	92.80	73.39	41.99	4.94	8.82	0.71	3.18
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	79.96	49.97	32.65	2.67	4.66	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	63.67	52.98	49.41	3.57	6.62	1.53	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	98.98	69.90	49.63	6.14	9.61	1.33	2.40
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	96.36	67.08	47.05	5.67	6.99	1.13	1.13
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	80.99	73.63	53.38	4.29	4.91	0.61	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	108.45	97.04	57.08	5.71	8.97	0.82	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	78.72	64.35	45.81	4.79	5.00	1.25	1.67
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	72.59	48.20	41.48	7.57	4.20	0.84	2.80
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	91.70	74.18	35.03	4.12	14.42	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	96.67	65.90	55.45	5.23	7.55	0.58	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	62.18	58.29	35.27	5.98	3.89	0.90	1.79
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	80.78	76.35	40.94	3.32	6.64	0.00	2.77
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	86.60	54.44	54.44	5.66	7.78	0.35	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	75.23	57.16	32.08	5.90	5.16	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	78.29	51.81	57.56	6.91	2.30	2.30	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	105.15	64.47	52.57	5.37	5.76	1.92	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	73.03	45.86	32.84	3.40	7.93	2.26	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	82.05	71.38	43.48	3.28	9.03	0.82	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	102.58	82.69	51.06	4.52	10.39	0.90	2.71
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	68.22	68.94	44.52	4.31	1.44	0.72	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	103.82	102.33	41.08	4.48	10.46	0.75	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	99.96	63.91	52.39	3.34	10.03	0.74	2.60
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	71.50	51.26	35.75	3.02	9.05	0.43	1.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	113.03	88.20	45.38	1.71	10.28	1.71	4.28
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	114.61	71.97	51.31	5.66	12.66	1.33	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	77.83	69.38	54.30	6.03	7.24	1.21	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	125.85	93.14	62.57	4.98	10.66	1.42	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	105.87	71.15	51.90	4.81	6.19	1.03	2.41
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	71.92	50.99	46.70	4.29	8.05	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	101.00	81.48	39.73	9.43	18.85	3.37	2.02
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	109.27	74.82	61.86	7.78	6.67	0.37	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	62.80	48.84	29.07	3.49	2.33	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	119.52	79.33	58.18	6.35	16.92	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	115.64	70.03	53.22	7.60	6.80	1.20	2.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	63.96	52.33	41.43	5.81	2.18	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	115.74	85.85	65.92	5.37	9.20	1.53	4.60
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	88.79	63.14	50.31	4.44	10.36	2.47	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	68.69	60.22	39.52	4.70	4.70	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	119.17	97.04	62.35	9.55	11.56	1.51	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	82.91	73.45	57.68	4.96	8.56	0.45	2.70
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	43.03	51.63	48.19	5.16	3.44	1.72	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	97.08	92.63	50.32	7.13	10.69	0.00	3.12
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	87.20	60.61	48.49	8.60	7.04	1.96	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	75.87	50.80	36.95	6.60	5.28	1.98	1.32
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	86.66	73.69	45.15	5.71	9.86	1.56	3.63
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	91.01	60.38	37.63	5.69	3.94	0.00	2.63
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	69.33	63.74	35.78	6.71	5.59	0.56	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	91.86	77.29	37.98	7.07	7.95	1.32	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	95.66	64.03	50.14	4.63	6.56	0.77	2.31
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	63.80	53.67	36.96	5.06	5.06	0.51	3.04
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	105.74	79.78	55.27	5.77	12.50	2.40	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	89.45	59.63	36.57	4.77	5.57	0.40	3.58
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	52.86	63.19	44.96	3.04	4.86	1.22	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	69.86	57.41	33.89	2.08	4.15	2.08	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	100.70	60.80	51.30	5.32	8.36	0.00	2.28
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	65.07	49.58	44.93	2.07	5.68	2.07	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	73.16	73.77	32.05	4.23	5.44	0.60	4.84
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	91.90	67.18	46.58	6.97	5.70	1.27	2.54
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	61.31	57.04	44.25	4.80	5.86	0.00	2.13
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	77.58	85.05	25.86	4.02	5.75	1.15	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	93.59	52.97	45.25	3.60	8.23	1.03	2.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	67.91	47.39	46.69	4.95	4.95	1.41	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	91.37	66.40	31.21	2.27	3.40	1.13	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	103.59	72.80	52.00	4.58	5.82	1.25	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	65.78	54.81	44.63	4.70	3.13	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	78.50	76.41	32.15	5.01	6.26	0.84	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	92.93	73.41	41.82	2.32	6.50	2.32	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	93.67	50.85	36.80	4.68	6.02	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	91.42	82.87	35.82	3.21	6.42	3.21	2.14
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	104.26	66.68	53.34	5.25	6.47	1.62	4.04
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	92.69	50.48	46.81	1.84	4.59	0.92	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	80.91	68.46	34.68	3.56	1.78	0.89	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	108.85	104.29	58.70	7.41	9.69	1.71	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	82.06	74.39	65.19	4.60	7.67	0.77	4.60
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	86.45	87.00	27.91	5.47	2.19	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	108.24	74.84	44.99	2.67	11.14	0.45	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	87.60	51.73	48.87	5.72	7.02	1.82	3.38
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	96.81	99.47	37.13	8.62	1.33	3.98	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	108.09	122.64	54.04	12.47	12.47	2.08	4.16
Macrophage - monocyte derived, donor1	11232-116C8	36.01	15.73	11.85	0.00	2.51	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	22.75	17.25	6.24	0.00	2.94	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	35.39	28.71	14.42	0.39	5.37	0.26	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	38.76	14.34	10.09	0.53	2.12	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	28.84	10.30	12.52	0.79	0.95	0.32	0.63
Mallassez-derived cells, donor3	11930-125I4	29.05	11.26	10.84	2.08	1.81	0.14	0.83
Mammary Epithelial Cell, donor1	11273-116H4	18.14	16.54	21.72	3.49	1.40	0.40	0.00
Mammary Epithelial Cell, donor2	11350-117G9	20.85	12.16	20.56	2.90	1.74	0.00	0.58
Mammary Epithelial Cell, donor3	11422-118F9	52.13	33.92	32.67	8.73	4.24	1.00	0.50
Mast cell - stimulated, donor1	11487-119E2	3.39	4.75	4.75	1.36	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	13.84	10.92	14.49	1.51	1.30	0.22	0.97
Mast cell, donor2	11565-120D8	16.05	12.48	15.45	2.38	1.19	1.19	2.97
Mast cell, donor3	11566-120D9	13.51	11.93	18.69	2.48	1.80	0.45	1.80
Mast cell, donor4	11567-120E1	15.07	10.11	14.71	3.72	0.53	1.06	3.72
Mast cell, expanded and stimulated, donor5	11940-126A5	10.98	10.98	4.44	1.44	0.67	0.00	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	8.17	9.92	9.34	4.67	0.58	1.17	2.33
Mast cell, expanded, donor5	11939-126A4	15.03	13.31	12.50	2.64	0.34	0.34	2.98
Mast cell, expanded, donor8	11941-126A6	21.76	14.56	15.90	4.85	0.33	0.33	2.34
Melanocyte - dark, donor1	11502-119F8	30.15	13.93	15.22	1.39	2.59	0.30	0.10
Melanocyte - dark, donor2	11582-120F7	42.57	17.65	23.53	5.54	3.11	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	22.38	20.86	29.70	2.61	2.46	0.22	0.14
Melanocyte - light, donor1	11274-116H5	26.09	26.33	25.39	3.53	2.35	0.00	2.35
Melanocyte - light, donor2	11351-117H1	23.20	19.79	42.31	1.36	2.73	0.00	5.46
Melanocyte - light, donor3	11423-118G1	38.16	35.56	51.17	6.07	6.07	0.00	5.20
Melanocyte, donor1 (MC+1)	12641-134G4	36.44	44.25	19.68	3.44	3.44	0.52	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	26.09	17.21	31.74	4.30	1.88	0.54	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	20.36	17.68	17.95	2.14	1.61	0.27	1.07
Meningeal Cells, donor1	11493-119E8	19.60	16.13	17.37	0.87	1.49	0.25	0.12
Meningeal Cells, donor2	11573-120E7	21.13	35.65	13.64	0.88	2.64	0.88	0.44
Meningeal Cells, donor3	11654-122E7	26.73	12.06	21.84	1.22	1.63	0.08	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	41.63	23.38	26.52	5.42	3.99	0.86	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	13.18	9.16	8.25	4.13	1.11	0.70	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	53.88	36.80	31.54	15.77	3.94	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	41.86	31.40	36.63	6.54	6.54	2.62	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	55.97	39.47	28.70	0.72	2.15	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	17.79	16.09	15.04	2.12	1.91	0.00	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	41.22	24.63	17.09	4.52	2.01	0.50	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	29.45	18.46	22.85	4.18	2.64	1.10	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	51.14	37.26	29.95	2.19	2.92	0.00	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	39.69	32.53	26.39	4.91	2.66	2.05	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	27.70	17.87	10.94	4.29	2.22	0.28	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	33.08	23.42	19.33	6.69	1.49	1.86	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	29.87	9.87	22.76	6.97	1.97	0.53	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	31.45	17.21	13.35	9.20	0.59	1.19	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	21.02	25.69	11.68	7.01	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	19.21	35.22	27.54	7.04	4.48	2.56	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	49.27	26.23	17.37	0.71	3.90	0.71	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	33.46	13.45	25.96	8.44	1.88	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	44.27	26.12	21.05	5.08	9.43	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	25.72	20.68	9.28	3.71	4.51	0.53	0.80
Mesothelial Cells, donor2	12156-128G5	37.53	15.01	9.51	3.50	4.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	29.12	24.64	13.66	3.18	3.54	0.58	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	18.90	18.90	5.40	0.00	1.35	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	25.12	18.96	8.37	0.25	1.48	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	24.15	17.08	7.66	0.00	3.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	44.94	27.66	10.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	15.81	12.40	6.51	0.00	0.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	12.24	13.48	8.71	0.21	2.49	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	16.21	11.58	23.16	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	28.78	18.27	3.25	0.00	4.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	15.83	13.03	7.45	0.00	2.33	0.47	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	25.40	17.68	7.72	0.20	2.64	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	14.65	16.23	9.90	0.00	2.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	25.65	0.00	0.00	25.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	28.32	14.16	4.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	20.52	15.20	6.08	0.00	2.28	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	23.69	10.53	15.79	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	19.10	13.79	6.79	0.00	2.55	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	18.42	9.21	3.68	0.00	4.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	21.16	14.60	2.68	0.30	2.68	0.00	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	21.80	11.74	8.38	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	33.95	33.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	18.07	11.29	6.02	0.00	2.26	0.00	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	13.78	8.79	6.18	0.24	2.14	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	37.04	11.61	6.63	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	22.56	16.81	3.45	0.00	4.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	16.20	11.15	5.68	0.00	2.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	29.35	14.47	7.75	0.00	3.26	0.00	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	27.46	12.66	4.93	0.00	3.22	0.00	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	16.89	12.23	4.89	0.00	1.78	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	41.27	10.32	0.00	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	20.37	11.17	2.63	0.00	2.41	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	15.21	18.76	6.59	0.00	1.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	16.57	14.91	9.94	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	23.92	15.76	3.26	0.00	2.72	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	19.41	13.82	5.29	0.00	1.47	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	28.35	6.54	11.99	0.00	3.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	37.96	18.26	9.61	0.00	2.88	0.00	1.44
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	16.01	11.61	5.20	0.00	1.60	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	46.62	37.02	5.48	0.00	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	42.55	18.02	6.51	0.00	2.50	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	42.81	14.27	8.15	0.00	4.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	27.59	17.95	5.69	0.44	1.75	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	30.90	23.18	9.93	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	44.19	39.06	7.68	0.00	3.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	33.96	15.62	7.19	0.00	1.74	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	16.70	16.01	6.96	0.00	1.39	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	72.93	39.78	15.47	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	34.53	17.09	7.86	0.00	2.74	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	30.63	25.38	7.00	0.00	3.50	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	48.65	36.57	12.07	0.00	4.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	34.23	14.87	6.73	0.28	5.33	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	28.68	22.03	6.65	0.00	3.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	51.86	36.71	11.07	0.00	4.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	43.14	28.66	10.56	0.30	3.02	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	30.89	22.96	11.69	0.42	2.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	43.31	28.88	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	40.64	28.63	13.85	0.00	1.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	24.47	24.47	11.95	0.00	3.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	38.69	29.02	11.61	0.28	2.07	0.14	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	36.02	24.36	8.81	0.00	3.37	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	33.03	30.46	9.44	0.00	4.72	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	43.19	36.84	13.97	0.00	3.81	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	33.36	23.22	8.01	0.00	2.67	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	26.34	30.53	12.27	0.30	3.29	0.00	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	30.23	19.07	10.17	0.14	1.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	42.36	22.30	9.24	0.00	2.87	0.00	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	30.29	25.43	13.27	0.00	2.43	0.22	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	37.16	34.13	18.58	0.00	3.79	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	27.84	20.46	6.82	0.00	3.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	27.04	28.51	10.57	0.25	4.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	33.89	29.33	16.94	0.00	4.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	27.34	22.05	6.47	0.00	2.06	0.00	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	29.70	25.66	11.82	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	15.25	10.30	9.89	0.00	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	18.76	9.83	6.25	0.00	1.49	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	3.77	3.77	0.00	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	21.39	14.26	3.56	0.00	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	23.99	18.07	11.83	0.00	3.29	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	31.56	17.88	10.52	0.00	3.16	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	17.59	8.90	6.33	0.00	1.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	18.63	16.76	6.52	0.00	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	15.40	25.16	7.51	0.00	1.88	0.00	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	25.57	17.84	14.12	0.00	2.40	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	21.60	8.82	8.48	0.00	1.36	0.00	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	16.94	14.73	5.89	0.00	2.21	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	19.05	15.02	10.99	0.00	3.30	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	37.33	14.00	7.78	0.00	0.00	0.00	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	21.91	5.34	7.48	0.00	1.07	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	23.18	0.00	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	31.31	25.25	17.17	0.00	0.00	0.00	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	18.13	18.97	10.12	0.00	1.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	5.45	2.72	1.36	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	6.36	0.64	1.91	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.86	1.62	1.62	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	1.51	9.06	0.00	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	0.00	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	3.26	6.52	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	14.26	4.75	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	25.10	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	29.95	16.80	18.31	2.59	1.72	0.43	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	19.34	29.79	9.93	2.09	1.57	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	12.68	53.40	6.01	0.67	3.34	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	34.64	76.80	12.52	1.25	2.92	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	40.88	82.52	7.23	1.52	6.46	0.38	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	35.11	54.26	19.15	3.19	1.60	1.60	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	12.24	30.60	6.12	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	97.39	42.27	14.70	0.00	3.68	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	8.37	23.86	5.86	1.67	0.84	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	26.50	61.60	12.55	1.86	2.09	0.23	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	13.51	38.91	4.86	1.08	3.51	1.08	1.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	16.19	25.23	11.35	1.26	1.26	0.21	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	11.13	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	12.91	37.72	9.43	2.48	2.98	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	21.38	36.81	6.23	1.08	1.62	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	10.43	34.23	5.89	1.36	1.36	0.23	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	24.82	40.83	9.47	2.45	2.78	0.16	0.82
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	17.86	18.77	6.93	1.64	0.36	0.18	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	11.14	34.48	2.12	2.12	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	14.41	32.42	6.00	2.40	0.60	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	48.57	46.60	7.88	0.66	6.56	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	14.47	34.64	4.88	1.95	1.30	0.00	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	17.11	23.81	8.47	0.71	1.76	0.18	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	12.66	28.83	4.92	4.22	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	16.55	39.53	7.82	3.68	1.84	0.00	1.84
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	15.42	38.88	7.71	0.96	1.93	0.00	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	37.94	56.91	8.97	2.07	4.48	0.34	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	136.54	118.84	2.53	0.00	7.59	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	14.26	20.94	4.23	0.89	1.11	0.00	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	11.43	46.57	3.39	1.69	1.27	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	17.33	28.48	5.70	2.85	1.66	0.00	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	13.74	41.64	5.58	1.72	1.29	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	9.03	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	10.00	33.32	5.00	2.33	2.67	0.33	1.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	13.98	30.66	7.66	0.90	1.35	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	13.49	26.98	4.76	3.17	1.98	0.40	1.59
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	12.07	28.79	8.36	0.93	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	21.57	47.67	3.78	1.51	2.65	0.76	3.03
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	20.53	35.20	2.28	0.98	0.98	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	11.77	48.81	2.61	1.31	1.31	0.44	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	17.19	19.90	4.52	0.90	1.36	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.94	30.87	3.53	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	5.32	21.94	3.99	0.66	1.33	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	10.91	36.21	7.44	0.00	1.49	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	14.16	40.58	2.68	0.77	1.91	0.38	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	20.87	33.27	4.84	1.51	2.72	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	14.81	16.13	3.54	1.55	1.55	0.22	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	14.91	49.47	6.78	2.03	1.36	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	71.53	0.00	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	10.97	39.63	4.88	0.61	1.22	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	11.65	46.90	3.46	1.26	1.57	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	9.68	35.11	2.12	2.12	1.82	0.00	1.82
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	11.08	29.27	4.75	0.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	75.95	78.22	5.67	0.00	2.27	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	70.81	5.06	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	31.43	18.39	13.42	2.36	3.11	0.75	0.87
Myoblast, donor2	11322-117D8	28.96	32.60	11.89	2.69	4.60	0.38	0.77
Myoblast, donor3	11398-118D3	25.56	20.01	8.24	0.84	3.53	0.00	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	73.84	135.43	75.89	16.64	7.15	3.21	0.88
Natural Killer Cells, donor1	11230-116C6	15.07	10.46	22.14	5.54	1.54	3.69	0.92
Natural Killer Cells, donor2	11311-117C6	21.71	12.36	28.95	9.05	1.21	4.52	0.90
Natural Killer Cells, donor3	11387-118C1	20.06	13.25	34.05	7.18	0.92	5.15	1.66
Neural stem cells, donor1	11275-116H6	22.50	23.59	35.21	7.26	2.54	2.54	0.73
Neural stem cells, donor2	11352-117H2	19.26	32.74	44.29	0.00	5.78	0.00	0.00
Neurons, donor1	11494-119E9	55.76	54.62	40.96	10.24	0.00	2.28	1.14
Neurons, donor2	11574-120E8	35.45	50.64	16.73	4.40	3.30	1.32	0.22
Neurons, donor3	11655-122E8	33.71	72.35	31.24	6.58	0.82	1.64	0.82
Neutrophils, donor1	11233-116C9	168.90	101.15	51.97	20.42	9.28	17.63	3.71
Neutrophils, donor2	11314-117C9	168.13	101.46	49.28	23.19	26.09	8.70	5.80
Neutrophils, donor3	11390-118C4	205.85	153.93	81.85	20.16	23.82	27.49	6.72
Nucleus Pulposus Cell, donor1	11252-116F1	35.98	19.83	29.57	7.01	1.54	0.71	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	36.47	32.23	35.49	7.49	3.26	0.65	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	27.28	31.49	21.46	5.82	2.01	0.40	0.40
Olfactory epithelial cells, donor1	11933-125I7	21.06	18.86	11.43	2.06	1.93	0.14	0.14
Olfactory epithelial cells, donor2	11934-125I8	30.69	23.01	11.58	2.89	1.30	0.29	0.43
Olfactory epithelial cells, donor3	11935-125I9	21.57	18.05	8.29	2.50	1.70	0.23	0.00
Olfactory epithelial cells, donor4	11936-126A1	22.11	23.47	11.01	2.82	3.02	0.19	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	40.92	21.67	24.07	3.61	4.81	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	27.44	17.87	17.23	5.53	2.77	0.85	3.40
Osteoblast - differentiated, donor2	11353-117H3	40.01	43.44	22.86	6.86	3.43	1.14	3.43
Osteoblast - differentiated, donor3	11425-118G3	34.14	27.93	31.66	7.45	4.34	0.00	0.62
Osteoblast, donor1	11277-116H8	41.82	31.27	29.32	10.36	3.71	3.52	0.78
Osteoblast, donor2	11354-117H4	35.82	17.56	20.37	1.40	4.21	0.70	0.00
Osteoblast, donor3	11426-118G4	46.21	45.50	44.08	6.40	5.51	0.89	1.07
Pancreatic stromal cells, donor1	11249-116E7	24.60	11.37	12.47	2.70	1.68	0.08	1.35
Pericytes, donor1	11491-119E6	26.93	31.04	24.14	3.00	1.11	0.33	0.33
Pericytes, donor2	11571-120E5	23.09	55.23	29.43	2.49	1.13	0.45	0.91
Pericytes, donor3	11652-122E5	41.50	40.28	21.77	5.29	3.66	1.22	0.20
Perineurial Cells, donor1	11499-119F5	23.73	18.20	19.21	2.26	3.39	0.57	0.23
Perineurial Cells, donor2	11579-120F4	24.84	15.64	15.55	5.34	3.50	1.01	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	30.92	10.20	21.04	4.14	1.27	0.96	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	37.46	20.57	39.18	4.16	1.22	3.18	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	31.45	22.00	33.65	5.44	1.81	1.55	0.26
Placental Epithelial Cells, donor1	11278-116H9	69.84	49.51	22.72	2.63	7.65	0.72	3.59
Placental Epithelial Cells, donor2	11355-117H5	57.66	29.94	37.70	1.11	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	44.76	38.48	32.98	3.14	2.94	0.39	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	32.91	35.76	17.40	0.95	2.85	0.00	1.90
Preadipocyte - breast, donor1	11467-119B9	13.51	8.44	11.26	1.31	1.13	0.56	1.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	16.97	6.53	11.88	0.26	2.09	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	32.65	21.84	26.34	1.58	2.03	0.23	0.68
Preadipocyte - omental, donor1	11468-119C1	16.62	11.40	12.36	3.30	1.92	0.21	2.13
Preadipocyte - omental, donor2	11329-117E6	20.08	16.15	15.28	1.31	0.87	0.44	0.87
Preadipocyte - omental, donor3	11403-118D8	27.07	36.53	14.90	2.86	4.01	0.57	0.57
Preadipocyte - perirenal, donor1	11469-119C2	25.59	21.65	10.83	5.91	0.98	1.97	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	61.73	27.95	16.89	3.69	2.15	0.92	2.46
Preadipocyte - subcutaneous, donor2	11356-117H6	32.05	30.10	21.43	4.78	3.72	0.89	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	36.78	31.16	27.93	4.43	5.45	0.68	1.87
Preadipocyte - visceral, donor1	11280-116I2	21.80	13.23	13.88	3.54	1.77	0.65	0.19
Preadipocyte - visceral, donor2	11357-117H7	32.21	23.47	23.47	5.52	3.22	1.38	0.00
Preadipocyte - visceral, donor3	11429-118G7	28.42	32.91	16.93	4.08	2.51	0.31	0.52
Prostate Epithelial Cells (polarized), donor1	11253-116F2	22.33	16.29	27.46	0.00	1.66	0.00	3.77
Prostate Epithelial Cells, donor2	11331-117E8	35.75	29.66	17.20	1.22	4.47	0.54	3.93
Prostate Epithelial Cells, donor3	11404-118D9	22.05	33.07	14.94	2.20	2.63	0.31	2.08
Prostate Stromal Cells, donor1	11254-116F3	28.13	15.49	16.29	4.44	1.59	0.80	1.37
Prostate Stromal Cells, donor2	11332-117E9	31.38	28.51	22.05	5.02	4.48	0.54	1.61
Prostate Stromal Cells, donor3	11405-118E1	32.12	26.90	20.23	8.55	3.23	0.63	3.55
Renal Cortical Epithelial Cells, donor1	11516-119H4	22.63	31.75	41.61	3.28	3.28	3.28	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	33.34	20.45	35.42	7.28	2.29	2.29	0.28
Renal Epithelial Cells, donor1	11517-119H5	48.19	39.56	57.32	14.20	4.57	3.04	0.00
Renal Epithelial Cells, donor2	11597-120H4	45.52	22.05	49.08	6.40	4.27	3.56	0.00
Renal Epithelial Cells, donor3	11678-122H4	27.10	14.93	36.52	4.87	1.69	2.65	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	39.49	27.23	23.15	2.72	5.45	1.36	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	28.70	32.07	14.42	3.10	1.62	1.35	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	42.40	31.75	23.76	2.89	3.77	1.55	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	41.92	38.60	33.94	3.99	3.33	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	34.33	22.01	32.35	10.12	3.74	4.18	0.66
Renal Mesangial Cells, donor2	11598-120H5	31.98	33.86	46.40	5.02	1.88	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	33.29	36.34	41.61	8.60	4.72	2.50	1.94
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	28.72	22.01	29.79	6.71	1.61	1.61	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	38.37	32.89	24.04	2.95	2.95	1.27	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	41.08	35.10	40.50	7.91	3.47	3.66	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	36.30	20.74	33.97	15.82	1.81	3.11	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	10.23	22.46	4.26	5.97	1.42	5.40	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	26.76	27.79	15.44	6.17	3.09	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	11.29	11.54	7.28	9.03	1.00	1.25	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	24.99	12.96	16.44	0.67	2.00	0.27	0.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	20.55	33.06	13.40	0.89	0.00	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	11.56	12.66	3.30	0.00	0.55	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	11.60	16.24	9.28	2.32	0.00	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	21.45	30.04	5.20	0.39	1.17	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	37.93	45.98	13.90	0.79	2.88	0.40	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	25.54	21.30	13.16	1.56	1.45	0.33	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	28.90	37.34	7.07	0.62	1.24	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	39.16	48.48	16.20	1.63	5.13	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	38.37	33.28	13.64	1.16	1.62	0.23	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	29.57	55.04	6.16	1.23	0.68	0.14	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	42.81	39.18	11.04	0.61	2.42	0.15	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	35.66	27.06	14.34	0.72	2.51	0.72	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	34.14	51.79	7.46	1.43	2.30	0.57	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	40.24	44.00	14.49	1.40	4.08	0.21	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	32.75	48.24	14.16	1.11	3.32	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	28.49	44.93	5.35	0.19	1.91	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	38.20	50.49	13.60	0.65	2.98	0.47	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	18.04	14.28	7.70	0.75	1.13	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	33.31	67.55	6.77	0.53	2.52	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	33.78	41.37	10.32	0.68	3.80	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	33.42	36.86	14.70	0.57	3.06	0.57	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	32.57	57.03	7.37	0.85	2.46	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	41.49	37.56	9.25	0.56	0.84	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	30.59	34.69	10.60	1.37	1.71	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	37.56	58.35	8.02	0.55	1.82	0.36	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	40.22	39.61	11.04	0.74	1.96	0.12	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	39.09	43.92	13.57	1.61	2.96	0.67	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	24.06	51.18	6.60	0.94	0.47	0.24	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	39.29	45.24	12.70	0.40	1.79	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	31.80	38.35	10.99	2.10	3.27	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	32.97	61.79	6.84	0.21	3.53	0.00	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	31.41	39.60	13.05	0.88	2.88	0.00	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	29.87	34.05	10.24	0.84	2.51	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	36.34	63.66	7.40	0.54	1.75	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	34.57	51.77	13.28	0.85	3.07	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	33.35	45.31	12.72	0.39	2.12	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	39.89	55.54	4.81	0.34	1.89	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	33.47	48.56	15.91	0.82	3.70	0.41	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	25.77	38.58	10.51	1.31	2.79	0.33	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	32.38	50.11	7.67	0.68	2.05	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	34.03	43.80	10.50	1.78	2.81	0.59	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	31.19	41.58	13.59	1.07	2.67	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	25.30	47.56	6.78	0.28	0.97	0.14	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	34.29	38.33	15.24	0.48	3.57	0.24	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	29.83	50.99	14.71	1.21	2.62	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	31.08	53.21	8.48	0.66	2.26	0.00	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	40.53	42.62	18.52	0.35	1.05	0.00	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	31.13	44.43	7.25	1.81	2.42	0.91	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	37.08	65.23	8.44	0.73	2.33	0.00	1.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	23.00	23.00	12.23	0.58	1.60	0.73	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	46.85	50.50	18.86	4.87	0.61	0.61	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	36.17	65.10	7.84	1.51	3.01	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	38.45	45.24	23.75	0.68	2.94	0.90	2.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	31.75	44.63	20.67	2.70	1.80	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	17.00	26.68	7.67	0.59	0.71	0.47	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	24.97	44.18	23.05	0.64	1.49	0.43	9.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	28.25	51.68	16.23	1.20	2.40	0.60	1.20
Schwann Cells, donor1	11498-119F4	30.47	50.97	46.27	3.76	2.26	2.44	0.94
Schwann Cells, donor2	11578-120F3	23.82	27.22	37.43	0.00	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	47.10	33.96	38.34	4.38	4.82	1.10	0.44
Sebocyte, donor1	11220-116B5	34.51	15.34	21.91	2.74	3.29	1.10	0.00
Sebocyte, donor2	11301-117B5	28.49	36.30	13.79	4.14	2.76	0.46	0.46
Sebocyte, donor3	11378-118B1	37.10	40.19	16.49	6.80	3.09	0.62	0.21
Sertoli Cells, donor1	11255-116F4	44.73	26.51	21.54	1.66	0.00	0.00	3.31
Sertoli Cells, donor2	11333-117F1	19.77	19.77	8.47	11.30	5.65	2.82	11.30
Skeletal Muscle Cells, donor1	11281-116I3	22.79	20.76	32.90	6.25	1.67	0.97	1.14
Skeletal Muscle Cells, donor2	11358-117H8	44.09	37.59	37.59	5.06	6.51	0.00	3.61
Skeletal Muscle Cells, donor3	11430-118G8	89.46	61.87	53.51	17.56	10.87	3.34	1.67
Skeletal Muscle Cells, donor4	11451-119A2	29.22	34.25	14.45	6.44	2.67	1.10	1.10
Skeletal Muscle Cells, donor5	11455-119A6	27.65	33.45	14.12	5.65	1.64	0.89	0.59
Skeletal Muscle Cells, donor6	11459-119B1	25.24	30.01	13.24	2.77	1.54	1.08	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	21.80	16.76	21.30	4.54	3.02	0.76	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	24.97	29.82	36.53	8.13	2.28	1.57	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	32.04	30.85	25.50	5.46	2.98	0.89	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	20.89	13.90	15.50	2.27	0.84	0.08	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	71.65	50.66	53.56	14.48	5.79	2.90	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	43.48	50.09	27.11	9.63	4.54	1.65	1.38
Skin - palm, donor1	10286-104F7	8.06	0.00	42.98	0.00	2.69	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	27.53	29.84	13.55	2.45	1.87	0.58	2.74
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	12.27	9.00	7.36	0.00	0.82	0.00	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	25.97	27.13	20.77	2.47	1.82	0.65	1.17
Small Airway Epithelial Cells, donor1	11256-116F5	22.10	13.76	20.02	0.56	1.95	0.14	2.50
Small Airway Epithelial Cells, donor2	11334-117F2	31.51	33.20	18.71	1.13	3.66	0.42	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	15.44	12.90	18.61	1.69	1.48	0.42	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	30.65	28.56	36.43	0.82	2.47	0.22	1.35
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	47.52	45.98	26.85	7.10	3.70	1.54	3.70
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	14.45	9.12	6.89	2.00	0.89	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	49.38	27.04	41.15	7.05	3.53	2.35	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	46.85	30.05	36.68	3.31	3.09	0.66	1.10
Smooth Muscle Cells - Aortic, donor2	11360-117I1	61.43	28.35	28.35	6.69	3.94	2.36	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	39.40	32.45	30.90	7.73	4.64	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	32.02	14.01	19.01	6.00	0.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	39.66	22.76	26.62	6.39	3.86	0.80	1.20
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	32.58	27.26	17.95	6.21	3.99	0.66	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	25.22	36.62	24.84	6.40	4.23	2.56	1.54
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	18.23	15.30	22.47	0.98	1.30	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	17.13	15.65	12.99	3.84	2.07	0.59	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	27.62	29.61	15.38	2.14	4.13	0.28	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	22.29	22.77	17.57	4.88	3.09	1.30	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	35.01	32.57	14.92	2.74	3.04	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	40.66	24.75	28.54	7.32	4.29	1.26	1.77
Smooth Muscle Cells - Carotid, donor2	11362-117I3	122.41	30.60	122.41	6.12	12.24	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	58.17	46.25	25.27	3.34	4.77	0.95	2.86
Smooth Muscle Cells - Colonic, donor1	11239-116D6	18.14	12.98	20.20	5.46	1.33	0.59	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	30.56	17.00	17.65	6.67	1.51	1.08	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	30.02	22.67	20.99	7.03	3.57	1.78	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	54.76	29.23	25.21	6.81	5.10	1.08	2.47
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	101.32	68.98	40.96	25.87	9.70	3.23	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	50.51	33.77	23.31	5.08	3.29	0.30	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	31.07	24.24	22.53	6.83	2.39	2.73	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	27.72	10.21	17.43	6.44	2.12	0.47	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	12.68	14.89	13.99	6.64	1.21	0.70	1.61
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	55.98	33.91	27.76	5.46	3.87	2.28	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	71.25	32.00	33.21	6.04	3.02	0.60	3.02
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	31.53	18.81	19.34	9.27	4.50	1.59	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	19.04	17.04	8.79	3.73	1.20	0.67	1.33
Smooth Muscle Cells - Prostate, donor2	11335-117F3	34.31	31.05	21.66	10.39	2.50	1.63	2.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	17.76	13.70	12.68	3.30	1.01	0.00	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	52.77	25.78	33.17	4.22	3.92	0.45	1.81
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	55.51	36.76	30.76	6.00	3.75	0.75	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	235.18	133.10	345.02	6.46	3.88	1.29	25.84
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	39.07	29.30	45.58	4.65	6.05	0.47	2.79
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	62.10	35.34	34.84	10.60	6.06	1.51	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	33.53	35.41	13.79	7.52	2.82	0.31	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	15.04	15.63	11.80	5.60	1.18	0.59	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	26.66	16.74	14.00	5.66	2.33	0.92	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	30.37	26.16	21.49	7.01	2.34	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	41.02	19.14	19.86	5.32	2.59	2.30	0.86
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	63.74	42.07	41.81	9.69	8.16	2.29	2.29
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	48.70	53.59	26.51	8.65	5.26	1.88	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	21.10	12.16	20.96	5.45	2.38	0.70	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	27.99	23.38	22.54	7.21	2.43	0.92	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	31.90	35.24	27.62	6.67	4.29	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	49.42	23.24	24.47	5.14	3.67	2.69	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	21.87	29.17	11.27	3.54	1.77	0.22	1.55
Smooth Muscle Cells - Uterine, donor3	11466-119B8	33.35	20.77	34.52	4.39	2.63	0.59	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	13.80	12.05	6.41	1.17	0.58	0.19	0.78
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	14.02	12.96	8.20	1.32	0.53	0.26	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	8.55	5.21	4.09	0.74	0.37	0.00	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	21.56	10.42	7.55	1.44	0.00	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	21.01	12.21	13.06	2.27	0.57	1.14	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	22.84	9.85	6.70	2.36	1.18	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	12.19	12.19	3.05	1.52	1.02	0.00	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	15.57	16.77	11.98	1.20	0.80	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	12.54	19.23	4.18	2.93	0.84	0.00	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	22.92	20.17	9.17	2.75	0.92	0.00	0.92
Synoviocyte, donor1	11291-117A4	21.04	12.12	15.49	1.01	1.01	0.34	0.84
Synoviocyte, donor2	11368-117I9	32.35	24.98	22.29	4.86	4.02	0.00	1.51
Synoviocyte, donor3	11440-118H9	27.70	27.26	10.05	2.90	1.56	0.45	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	38.95	27.87	38.95	8.22	3.93	2.14	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	45.59	27.75	11.89	7.93	3.96	5.95	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	42.84	49.55	34.04	10.65	4.17	2.55	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	22.22	15.20	25.30	3.94	0.93	0.57	0.79
Tracheal Epithelial Cells, donor2	11369-118A1	49.09	32.47	37.88	6.57	4.25	0.77	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	46.96	38.37	29.21	2.86	2.86	1.15	1.72
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	28.54	14.02	15.50	0.74	1.97	0.25	0.37
Urethra, donor2	10319-105A4	5.40	7.19	19.78	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	28.96	16.47	15.67	1.59	2.13	0.27	0.00
Urothelial Cells, donor2	11600-120H7	27.24	19.63	19.23	0.80	4.01	0.00	0.00
Urothelial Cells, donor3	11681-122H7	34.61	26.13	21.09	0.92	2.06	0.00	0.23
Urothelial cells, donor0	11216-116B1	32.77	19.39	21.18	1.11	1.34	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	103.21	56.95	27.58	3.56	3.56	1.78	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	77.20	47.18	17.16	4.29	5.72	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	130.06	57.50	39.02	4.79	14.37	0.68	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	60.95	26.17	21.35	3.44	3.10	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	63.33	24.98	25.57	5.81	1.74	0.58	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	91.63	45.81	22.91	5.21	4.16	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	61.49	44.97	18.36	2.75	5.51	1.84	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	115.03	55.69	29.21	3.65	7.30	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	17.39	32.57	19.74	11.23	2.22	6.66	0.25
Wilms' tumor cell line:HFWT	10597-108E3	22.88	30.80	24.64	0.00	2.64	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	23.18	33.24	17.32	0.00	0.28	0.00	0.00
achilles tendon, donor2	10292-104G4	24.80	22.73	33.06	0.00	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	24.73	19.63	45.64	3.31	1.27	0.76	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	13.70	10.68	22.06	0.93	0.93	0.46	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	20.66	12.23	23.74	6.53	0.71	1.31	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	14.97	15.24	16.87	0.00	0.82	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	16.58	26.14	24.17	1.12	0.84	0.56	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	25.59	20.09	14.80	0.21	2.33	0.00	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	19.05	14.70	19.33	0.82	0.54	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	18.07	26.44	15.86	0.88	0.88	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	23.68	19.60	18.78	0.41	1.63	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	43.88	80.77	20.19	0.78	6.21	0.00	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	19.14	11.04	16.56	0.00	1.84	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	7.80	7.80	7.80	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	25.33	21.84	24.86	0.00	1.63	0.00	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	16.31	17.86	12.69	0.26	0.78	0.00	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	25.72	16.37	22.50	0.29	1.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	20.91	19.52	32.53	0.46	0.46	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	44.83	23.44	51.00	0.41	0.82	0.00	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	24.56	47.88	15.04	0.31	1.53	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	21.34	14.08	20.91	1.71	1.28	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	22.44	12.13	18.20	0.30	2.12	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	19.98	15.16	26.24	0.72	1.44	0.00	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	28.96	19.38	16.48	0.45	2.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	20.01	14.34	15.68	0.00	1.67	0.67	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	31.59	61.32	46.46	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	15.07	18.83	5.65	2.26	0.75	0.75	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	14.83	14.83	5.67	0.44	0.87	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	11.25	39.36	9.37	0.00	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	36.97	23.31	18.60	0.24	1.65	0.24	0.47
adipose tissue, adult, pool1	10010-101C1	20.63	7.76	19.86	0.62	1.71	0.47	1.24
adipose, donor1	10184-103D4	1.17	6.45	14.66	2.35	0.00	0.00	2.35
adipose, donor2	10185-103D5	6.89	33.25	34.47	5.27	1.22	3.24	1.62
adipose, donor3	10186-103D6	25.87	33.22	40.84	4.63	0.82	2.72	1.91
adipose, donor4	10187-103D7	78.01	47.67	93.61	5.20	0.87	3.47	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	18.31	80.49	12.63	0.63	1.58	0.16	0.16
adrenal gland, adult, pool1	10081-102A9	36.38	47.29	25.46	10.91	7.28	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	21.61	18.68	31.35	3.20	1.07	0.40	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	33.59	22.15	30.37	0.00	2.86	0.00	0.71
amniotic membrane cells, donor1	12235-129G3	25.50	14.14	13.91	0.00	2.78	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	34.82	29.08	20.62	3.72	2.70	0.34	2.37
amniotic membrane cells, donor3	12237-129G5	25.63	23.86	7.37	0.59	2.36	0.00	0.88
amygdala - adult, donor10196	10167-103B5	18.97	18.97	13.04	0.00	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	39.54	25.55	15.21	2.64	3.04	0.41	0.00
amygdala, newborn, donor10223	10360-105E9	18.08	19.04	6.13	1.29	0.00	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	16.43	13.62	13.62	0.38	1.40	0.13	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	43.24	92.00	22.72	0.44	6.84	0.22	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	16.70	16.03	13.36	4.01	1.34	0.33	0.67
aorta, adult, pool1	10052-101G7	16.67	24.12	20.40	0.59	1.57	0.00	0.20
appendix, adult	10189-103D9	21.35	12.03	20.96	1.16	1.94	0.00	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	31.64	21.67	36.11	6.88	0.69	4.13	0.34
artery, adult	10190-103E1	19.02	5.43	19.02	0.00	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	15.79	14.63	29.84	0.29	0.58	0.29	0.00
b cell line:RPMI1788	10427-106D4	10.41	10.71	9.67	0.45	0.74	0.30	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	34.13	13.32	11.10	1.39	1.66	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	20.94	12.01	8.04	0.99	1.79	0.10	0.10
bile duct carcinoma cell line:TFK-1	10496-107C1	7.20	5.86	3.51	0.00	0.17	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	16.22	22.37	12.86	0.00	1.12	0.56	0.56
bladder, adult, pool1	10011-101C2	22.16	11.52	15.64	1.09	1.41	0.11	0.98
blood, adult, pool1	10053-101G8	46.51	86.37	37.65	6.64	6.64	4.43	11.07
bone marrow stromal cell line:StromaNKtert	10686-109F2	20.55	12.85	11.13	0.00	0.00	0.00	0.86
bone marrow, adult	10192-103E3	34.42	18.90	17.55	0.67	2.70	0.00	0.67
brain, adult, donor1	10084-102B3	20.50	34.85	20.50	1.03	1.03	1.03	6.15
brain, adult, pool1	10012-101C3	20.04	13.25	16.26	1.56	1.45	0.33	0.11
brain, fetal, pool1	10085-102B4	58.77	66.78	48.09	5.34	5.34	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	57.81	64.42	23.46	0.00	5.95	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	22.97	15.48	6.24	9.36	1.37	0.37	0.00
breast, adult, donor1	10080-102A8	41.04	42.93	9.47	3.16	1.26	0.00	3.79
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	25.15	28.20	19.69	0.89	4.07	0.13	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	26.59	29.07	20.72	0.93	0.93	0.31	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	13.35	5.53	8.06	0.00	0.23	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	35.59	47.93	30.74	7.99	2.42	0.48	0.24
carcinoid cell line:NCI-H1770	10703-109H1	23.51	35.73	65.82	7.52	1.41	0.47	0.94
carcinoid cell line:NCI-H727	10735-110B6	25.60	12.14	36.86	0.00	0.98	0.00	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	25.35	70.03	31.69	1.58	0.95	0.00	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	22.36	38.60	21.56	9.58	1.06	1.60	0.80
caudate nucleus - adult, donor10196	10177-103C6	18.42	24.18	5.76	0.00	1.15	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	48.36	24.43	22.42	3.68	5.52	1.17	0.33
caudate nucleus, adult, donor10258	10379-105H1	34.39	26.74	13.75	2.29	1.53	0.76	0.76
caudate nucleus, newborn, donor10223	10354-105E3	24.90	22.71	10.62	4.03	0.73	0.73	0.37
cerebellum - adult, donor10196	10173-103C2	8.74	2.91	17.48	0.00	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	37.79	19.86	20.50	0.85	3.84	0.43	0.00
cerebellum, adult, pool1	10083-102B2	14.83	13.45	13.45	1.38	1.38	0.00	0.69
cerebellum, newborn, donor10223	10357-105E6	10.79	14.11	5.81	1.66	0.00	0.83	0.00
cerebral meninges, adult	10188-103D8	26.98	22.69	12.35	2.27	1.76	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	7.31	11.69	12.43	2.19	0.00	0.00	1.46
cervical cancer cell line:D98-AH2	10552-107I3	13.23	20.56	9.06	0.29	1.15	0.00	0.58
cervical cancer cell line:ME-180	10553-107I4	11.27	11.10	7.62	0.00	1.33	0.00	0.00
cervix, adult, pool1	10013-101C4	26.88	14.70	20.47	2.83	1.99	0.00	1.47
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	12.12	24.80	6.97	1.11	1.25	0.28	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	14.37	27.43	16.98	0.00	2.61	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	11.56	13.05	22.12	0.00	1.74	0.00	1.24
choriocarcinoma cell line:SCH	10785-110H2	28.22	25.14	25.75	0.00	1.23	0.12	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	15.18	14.94	11.62	0.00	0.95	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	25.07	18.52	14.82	0.28	2.28	0.28	0.57
chorionic membrane cells, donor2	12239-129G7	36.39	25.85	25.55	4.18	3.28	0.70	6.07
chorionic membrane cells, donor3	12240-129G8	26.38	25.28	7.69	1.65	0.55	0.00	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	26.25	18.18	29.28	6.06	0.00	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	17.29	24.40	11.53	0.19	1.34	0.19	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	10.98	26.40	12.46	0.00	2.11	0.42	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	23.63	23.88	18.49	0.00	2.31	0.77	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	30.48	29.27	14.03	0.48	0.48	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	23.21	25.04	11.40	0.20	1.63	0.41	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	15.61	8.54	10.89	0.00	0.88	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	14.33	13.03	7.30	0.52	0.78	0.52	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	30.86	26.06	29.03	0.00	1.37	0.00	1.60
clear cell carcinoma cell line:TEN	10636-108I6	25.68	9.54	19.61	0.00	0.69	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	18.12	13.00	19.59	0.00	1.28	0.00	0.55
colon carcinoma cell line:COLO-320	10420-106C6	7.60	6.84	17.10	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	23.80	8.33	32.13	2.38	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	17.63	7.05	29.61	0.94	1.18	0.12	3.88
colon, fetal, donor1	10070-101I7	39.55	31.52	21.01	0.62	1.24	0.00	2.47
common myeloid progenitor CMP, donor1	12130-128D6	9.17	55.00	9.17	0.00	4.58	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	8.07	4.67	9.77	3.40	0.00	1.27	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	10.11	4.98	18.41	2.11	1.36	2.41	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	17.77	9.73	14.10	3.10	1.27	2.54	0.71
corpus callosum, adult, pool1	10042-101F6	19.57	8.51	15.37	1.22	1.00	0.11	0.00
cruciate ligament, donor2	10295-104G7	21.88	16.21	22.69	0.81	0.00	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	19.26	25.68	9.63	0.80	1.61	0.00	2.41
diencephalon, adult	10193-103E4	24.48	24.72	11.04	1.68	1.68	0.24	1.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	11.94	10.79	24.80	0.23	0.92	0.00	0.46
ductal cell carcinoma cell line:KLM-1	10438-106E6	18.21	13.59	20.00	0.00	0.26	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	16.85	16.85	15.89	0.00	0.96	0.00	0.72
ductus deferens, adult	10196-103E7	22.92	11.46	26.41	1.00	0.50	0.00	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	14.40	31.69	8.64	0.00	2.88	0.00	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	29.43	12.51	20.60	2.21	0.74	0.00	0.00
dura mater, adult, donor1	10041-101F5	22.05	16.60	30.97	1.73	1.73	0.41	1.16
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	9.55	15.10	24.21	0.22	0.89	0.00	2.66
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	13.90	17.63	25.94	0.00	0.29	0.29	1.15
embryonic pancreas cell line:1B2C6	10604-108F1	7.40	9.87	5.55	1.23	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	12.71	10.59	9.38	1.21	0.91	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	11.42	11.42	5.87	1.23	0.93	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	13.13	22.33	6.57	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	21.12	20.45	25.81	0.00	1.34	0.00	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	35.88	29.00	23.38	6.89	3.81	0.00	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	28.95	15.76	9.97	0.00	1.45	0.16	0.32
epidermoid carcinoma cell line:A431	10426-106D3	19.90	13.12	11.67	0.00	0.89	0.00	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	30.80	23.54	20.46	0.00	2.42	0.00	0.33
epididymis, adult	10197-103E8	23.65	15.91	19.47	1.26	0.84	0.84	1.88
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	20.05	18.98	15.43	8.16	1.42	1.42	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	21.63	20.45	17.70	1.97	1.57	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	35.38	18.61	16.64	0.00	3.93	0.26	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	32.08	18.90	16.73	0.00	1.87	0.00	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	33.50	22.97	18.15	0.00	2.69	0.00	0.56
esophagus, adult, pool1	10015-101C6	40.14	13.70	31.43	0.74	2.34	0.00	2.02
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	15.03	10.90	12.02	31.68	0.63	2.63	0.88
eye - muscle inferior rectus, donor1	10272-104E2	12.07	2.41	21.73	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	10.52	14.73	16.83	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	8.93	5.95	13.39	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	8.03	9.17	17.20	1.15	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	21.86	30.61	21.86	1.46	0.00	1.46	1.46
eye, fetal, donor1	10054-101G9	29.75	26.19	9.92	2.03	3.31	0.00	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	13.21	21.03	8.85	1.15	1.41	0.13	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	14.25	40.12	8.55	1.42	1.66	0.24	0.47
frontal lobe, adult, pool1	10040-101F4	14.26	10.32	12.67	2.16	1.50	0.47	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	9.01	12.91	8.41	0.30	0.90	0.00	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	16.00	16.73	8.78	0.09	0.82	0.00	0.09
gall bladder, adult	10198-103E9	25.59	13.28	22.94	1.93	1.93	0.00	0.97
gamma delta positive T cells, donor1	11937-126A2	28.45	11.81	15.03	10.74	2.15	0.54	1.07
gamma delta positive T cells, donor2	11938-126A3	26.52	8.22	20.92	10.08	1.49	4.11	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	23.66	39.08	14.79	0.42	1.48	0.00	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	23.60	13.54	17.79	0.00	1.55	0.19	0.00
gastric cancer cell line:AZ521	10549-107H9	14.26	15.74	17.05	8.36	0.82	1.64	0.00
gastric cancer cell line:GSS	10560-108A2	7.32	8.24	11.90	0.00	0.92	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	16.22	14.39	15.76	0.46	0.23	0.23	0.46
giant cell carcinoma cell line:LU65	10487-107B1	8.49	7.92	3.79	0.23	0.46	0.00	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	6.30	6.86	3.64	4.20	1.26	0.70	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	24.69	21.95	14.72	0.75	1.00	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	22.80	15.09	18.37	3.80	1.79	1.06	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	20.22	18.82	17.70	3.37	2.11	0.70	0.00
glioblastoma cell line:T98G	10485-107A8	15.01	9.05	18.21	1.21	1.10	0.33	0.00
glioma cell line:GI-1	10413-106B8	20.21	14.64	19.33	2.93	1.17	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	16.04	16.76	5.10	1.46	2.19	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	37.59	24.90	15.87	1.95	3.42	0.24	0.24
globus pallidus, adult, donor10258	10367-105F7	17.80	31.49	20.54	0.00	0.00	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	27.71	17.59	4.80	2.13	0.00	1.07	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	51.39	36.71	14.68	0.00	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	21.86	54.64	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	15.68	31.36	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	11.20	13.44	10.88	0.96	1.92	0.00	0.64
hIPS +CCl2, biol_rep1	14383-156B9	16.53	20.20	13.77	1.38	0.00	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	17.83	6.86	14.18	2.29	0.46	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	10.31	14.81	12.24	1.93	0.64	0.64	0.64
hIPS, biol_rep1	14380-156B6	4.31	8.62	7.19	0.00	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	6.86	13.03	17.83	0.00	0.00	0.69	1.37
hIPS, biol_rep3	14382-156B8	15.45	16.55	6.62	0.00	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	12.36	23.85	8.62	12.64	0.86	5.46	0.00
heart - mitral valve, adult	10205-103F7	23.92	9.57	19.43	0.90	1.20	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	20.40	8.37	14.90	1.05	0.78	0.00	0.78
heart - tricuspid valve, adult	10207-103F9	45.80	19.98	14.15	3.33	0.83	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	19.79	29.59	23.87	0.61	0.41	0.20	0.41
heart, adult, diseased, donor1	10051-101G6	14.90	20.01	32.36	0.43	1.28	0.43	0.85
heart, adult, pool1	10016-101C7	32.89	14.95	25.30	0.69	3.45	0.46	1.61
heart, fetal, pool1	10046-101G1	19.82	9.96	24.13	1.13	1.95	0.41	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	20.98	31.16	11.72	0.93	0.93	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	1.19	10.70	10.70	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	19.12	17.79	16.80	0.00	2.43	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	19.42	19.42	21.60	0.00	1.46	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	18.29	16.47	14.45	0.00	2.22	0.00	0.10
hepatoma cell line:Li-7	10484-107A7	17.13	9.34	13.79	0.00	0.67	0.00	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	14.37	24.82	17.29	0.00	0.60	0.00	0.10
hippocampus - adult, donor10196	10169-103B7	15.14	33.12	5.68	0.95	1.89	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	34.29	29.39	17.76	2.45	3.06	0.20	0.20
hippocampus, adult, donor10258	10374-105G5	6.47	6.97	11.45	0.00	0.50	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	21.50	27.49	7.05	0.35	1.06	0.35	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	17.09	14.65	12.21	3.05	1.22	2.44	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	16.69	29.85	10.41	5.69	2.36	2.55	1.57
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	17.77	19.04	16.50	5.08	0.25	3.05	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	5.64	15.79	27.07	7.89	0.00	4.51	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	5.16	25.56	35.37	11.88	0.00	2.84	3.61
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	4.93	11.77	37.96	9.11	0.38	3.04	4.56
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	8.17	14.60	23.06	3.50	0.00	3.80	2.34
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	8.40	18.31	29.30	8.19	0.00	2.15	3.45
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	13.76	16.27	24.19	6.26	0.83	2.09	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	15.63	15.15	26.99	3.32	1.66	3.55	1.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	13.34	27.96	33.11	7.55	1.13	4.34	3.38
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	17.51	15.49	20.87	3.37	1.35	1.35	4.71
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	12.99	18.62	11.74	6.89	1.25	3.13	1.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	19.65	25.06	12.28	2.46	1.97	3.44	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	11.35	5.24	8.73	5.24	1.75	2.62	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	8.97	16.99	38.95	8.97	0.38	2.10	2.29
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	7.85	19.19	37.50	6.54	0.87	1.31	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	6.00	13.99	22.99	4.00	1.00	0.50	3.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	6.78	21.85	36.36	7.16	0.38	5.84	2.64
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	8.18	21.37	32.28	6.37	0.00	5.91	5.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	4.39	16.29	23.18	3.45	0.63	3.76	3.13
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	7.35	17.80	32.82	4.74	0.98	3.59	1.14
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	6.39	20.61	28.16	4.06	1.45	1.45	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	7.47	13.75	25.71	2.99	0.60	2.39	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	20.32	26.23	23.65	9.61	1.29	3.69	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	17.12	26.82	19.11	6.28	0.57	2.57	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	18.37	18.37	20.42	6.53	0.82	3.27	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	8.45	15.84	36.26	6.69	0.70	3.87	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	5.07	20.27	33.57	10.77	0.95	2.85	2.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	6.66	13.32	30.87	6.36	0.00	2.42	2.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	5.69	18.62	25.34	4.14	0.52	1.55	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	5.98	19.26	15.28	1.33	0.66	1.33	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	7.95	9.75	23.34	4.36	0.51	3.08	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	9.20	18.66	27.35	3.07	1.79	3.83	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	9.09	15.90	28.77	1.51	0.76	1.51	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	9.75	16.13	22.85	3.70	0.34	3.36	2.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	16.42	23.91	15.94	7.00	1.21	3.86	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	20.05	8.02	13.82	8.02	0.45	1.78	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	19.02	25.85	15.12	8.29	0.98	4.39	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	5.81	13.14	38.51	9.17	0.61	3.06	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	6.51	0.00	6.51	3.25	0.00	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	2.98	7.61	23.17	12.58	0.33	1.65	3.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	5.47	12.59	38.86	6.57	0.00	2.19	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	7.24	10.13	31.85	7.96	0.72	2.90	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	4.98	10.32	29.18	10.32	0.36	2.49	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	4.77	13.13	31.03	7.16	0.00	1.19	8.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	9.75	14.49	34.67	5.28	0.54	4.74	3.79
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	15.09	18.32	34.21	8.62	0.27	4.31	2.16
immature langerhans cells, donor1	11904-125F5	23.97	11.87	7.02	0.00	1.70	0.00	0.00
immature langerhans cells, donor2	11905-125F6	31.69	22.97	15.84	0.00	2.38	1.58	0.79
insula, adult, pool1	10039-101F3	10.60	12.49	18.83	1.61	1.51	0.38	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	38.04	45.85	31.86	0.65	2.60	0.33	2.28
kidney, adult, pool1	10017-101C8	20.63	11.01	20.83	0.60	1.20	0.20	0.70
kidney, fetal, pool1	10045-101F9	23.84	14.71	30.13	2.12	1.98	0.50	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	15.91	20.59	8.24	0.28	1.14	0.00	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	27.79	8.99	22.12	0.41	0.83	0.00	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	12.29	18.90	8.07	0.00	1.10	0.00	0.00
left atrium, adult, donor1	10079-102A7	21.79	28.33	7.63	0.54	0.54	0.00	0.54
left ventricle, adult, donor1	10078-102A6	22.75	31.35	21.24	0.51	1.01	0.00	1.52
leiomyoblastoma cell line:G-402	10721-110A1	20.79	36.39	10.94	0.00	2.74	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	27.30	22.99	14.73	11.14	3.95	1.08	3.95
leiomyoma cell line:15242A	10570-108B3	20.11	21.74	16.85	10.87	1.63	1.63	0.54
leiomyoma cell line:15425	10571-108B4	34.24	24.04	14.57	10.44	2.67	1.46	2.67
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	19.05	19.05	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	15.68	11.50	9.41	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	17.47	26.09	17.24	0.59	1.77	0.59	0.12
liposarcoma cell line:KMLS-1	10782-110G8	16.87	22.34	13.75	2.97	0.94	0.94	0.31
liposarcoma cell line:SW 872	10726-110A6	42.52	30.95	56.78	0.49	2.44	0.24	0.24
liver, adult, pool1	10018-101C9	37.92	21.55	18.96	1.30	2.27	0.32	1.94
liver, fetal, pool1	10086-102B5	29.16	51.74	29.16	0.00	2.82	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	18.52	15.75	10.94	1.02	1.60	0.73	0.44
locus coeruleus, adult, donor10252	10165-103B3	31.74	15.50	15.13	1.66	3.88	0.37	0.00
locus coeruleus, adult, donor10258	10375-105G6	14.67	23.42	17.77	0.85	0.56	0.28	0.85
locus coeruleus, newborn, donor10223	10362-105F2	21.03	8.41	2.94	1.26	0.42	0.42	0.42
lung adenocarcinoma cell line:A549	10499-107C4	8.30	4.84	9.55	0.00	0.14	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	26.20	20.68	14.48	0.00	2.07	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	27.15	22.94	23.20	0.00	1.19	0.26	0.66
lung, adult, pool1	10019-101D1	20.20	17.13	22.56	2.36	1.89	0.35	1.65
lung, fetal, donor1	10068-101I5	25.97	22.26	7.99	1.71	0.86	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	27.03	35.28	21.99	0.00	2.29	0.46	0.92
lymph node, adult, donor1	10077-102A5	40.71	44.97	15.62	7.10	3.31	0.47	2.37
lymphangiectasia cell line:DS-1	10727-110A7	8.77	14.90	7.67	0.00	0.66	0.00	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	25.36	28.83	45.28	0.75	3.17	0.15	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	15.29	9.34	5.95	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	20.87	12.88	15.54	0.89	1.33	0.00	1.78
mature adipocyte, donor2	12232-129F9	18.68	11.41	15.77	0.83	1.04	0.00	0.00
mature adipocyte, donor3	12233-129G1	18.73	10.19	18.25	0.95	1.19	0.00	0.95
mature adipocyte, donor4	12234-129G2	21.85	10.53	11.84	1.05	1.84	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	8.82	11.67	12.87	0.00	0.71	0.00	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	12.41	21.43	7.90	3.38	1.13	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	32.92	18.94	10.11	0.92	3.49	0.37	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	13.98	19.70	11.12	0.32	0.32	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	20.90	13.22	7.68	0.43	0.00	1.28	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	21.09	16.37	12.66	1.52	1.01	0.00	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	31.41	24.41	13.16	1.91	2.97	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	15.41	11.56	11.56	0.00	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	14.35	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	17.59	17.59	8.26	1.44	1.08	0.36	1.08
medulla oblongata - adult, donor10196	10174-103C3	10.38	17.52	5.19	0.00	1.30	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	28.48	17.65	13.00	1.24	3.56	0.46	0.15
medulla oblongata, adult, pool1	10038-101F2	17.22	12.00	14.37	1.14	0.90	0.41	0.08
medulla oblongata, newborn, donor10223	10361-105F1	29.51	21.18	7.99	1.74	1.04	0.00	0.35
medulloblastoma cell line:D283 Med	10838-111E1	10.18	9.08	4.87	3.32	0.22	0.66	0.44
medulloblastoma cell line:ONS-76	10759-110E3	30.57	34.48	33.75	1.59	2.32	0.12	0.37
melanoma cell line:COLO 679	10514-107E1	10.92	8.34	17.82	0.72	1.15	0.29	1.01
melanoma cell line:G-361	10465-106H6	11.94	7.33	21.45	2.17	0.54	0.27	2.44
meningioma cell line:HKBMM	10691-109F7	26.95	14.47	28.40	0.18	1.63	0.18	0.72
merkel cell carcinoma cell line:MKL-1	10843-111E6	29.08	16.74	39.65	1.76	0.00	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	35.51	47.70	31.63	8.30	1.81	2.33	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	29.15	26.08	15.96	6.29	1.38	0.77	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	22.72	22.00	11.27	10.18	1.45	0.91	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	12.01	20.29	9.52	4.14	0.83	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	16.15	18.96	12.08	5.34	2.25	0.28	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	22.72	23.49	7.70	2.70	1.35	0.58	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	20.13	11.80	11.11	3.47	3.47	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	13.90	13.90	10.64	6.01	2.06	0.69	0.86
mesenchymal precursor cell - cardiac, donor2	11753-123G7	20.13	23.92	8.28	4.14	1.50	0.23	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	27.59	24.27	11.54	4.24	2.39	0.53	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	32.81	26.87	12.69	5.54	2.43	1.08	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	26.60	23.19	9.10	4.27	1.28	0.71	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	12.52	11.53	11.20	3.29	1.98	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	22.69	26.57	11.07	3.87	2.08	0.69	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	31.42	16.76	13.96	1.75	1.75	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	16.95	18.99	10.82	3.27	1.02	0.41	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	18.69	15.46	12.94	2.16	3.24	0.36	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	21.93	19.14	10.03	1.97	2.28	0.10	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	22.57	20.75	10.72	1.82	2.51	0.46	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	7.55	15.94	6.29	3.36	2.10	1.26	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	20.77	18.53	13.00	1.34	1.94	0.30	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	24.51	24.33	10.33	3.06	1.49	0.79	0.61
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	20.25	16.57	11.78	1.10	1.10	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	22.03	19.46	17.46	1.72	1.72	0.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	24.00	30.31	20.63	3.37	2.95	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	26.49	26.49	20.55	1.37	1.83	0.00	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	24.30	19.70	18.16	2.56	1.28	0.26	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	24.34	24.34	16.23	3.14	1.83	0.26	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	28.65	23.72	15.40	1.23	2.16	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	22.36	16.95	14.12	1.88	4.24	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	19.63	27.75	14.22	2.03	2.71	0.68	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	25.94	20.43	19.26	2.36	1.96	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	20.85	18.54	12.97	1.85	1.85	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	48.30	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	30.28	29.13	19.04	2.60	2.60	0.00	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	24.54	22.53	17.18	2.45	2.68	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	23.55	21.15	18.75	1.68	2.16	0.24	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	18.33	28.60	9.53	3.67	0.73	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	24.84	21.48	16.78	5.71	1.01	0.34	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	24.56	17.19	15.15	2.05	3.68	0.41	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	18.04	22.34	19.33	4.73	3.44	0.00	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	19.14	16.41	8.20	2.73	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	36.15	5.16	10.33	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	24.36	18.19	17.54	4.22	1.62	0.32	1.62
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	24.73	18.91	11.64	1.45	1.45	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	18.66	28.25	13.86	2.13	2.13	0.53	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	22.90	17.99	17.99	1.64	1.64	0.00	3.27
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	26.82	22.55	13.22	0.39	1.17	0.00	1.94
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	20.99	6.30	4.20	0.00	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	18.88	14.90	13.91	2.98	0.00	0.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	28.60	14.30	9.53	9.53	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	21.94	11.86	13.64	1.19	2.37	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	26.81	25.59	13.40	3.66	3.66	0.00	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	21.54	14.57	15.83	2.53	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	15.52	15.18	6.55	4.48	0.69	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	17.19	12.90	10.75	0.00	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	35.93	0.00	7.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	24.11	6.89	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	24.04	14.67	6.11	3.67	1.63	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	20.66	20.66	6.36	3.97	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	21.22	19.45	7.07	4.72	2.36	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	19.95	12.16	7.79	4.68	2.18	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	29.41	12.03	8.02	4.01	2.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	22.47	15.37	10.64	2.37	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	20.54	23.11	12.84	5.14	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	18.59	10.33	13.08	1.38	2.07	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	24.25	24.25	17.81	0.99	3.46	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	19.07	44.86	10.09	1.12	6.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	29.26	21.63	11.45	0.00	1.91	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	23.78	37.48	16.93	0.00	2.42	0.40	1.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	26.17	19.63	13.08	0.00	6.54	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	26.61	27.88	12.67	1.27	3.80	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	15.17	22.45	10.92	0.00	1.82	0.00	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	49.71	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	20.59	38.71	18.94	1.65	3.29	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	11.91	9.72	3.57	0.99	1.39	0.00	1.19
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	20.12	23.36	13.95	1.62	0.97	0.00	1.62
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	29.54	8.15	9.17	1.02	1.02	0.00	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	27.85	13.93	9.28	0.77	2.32	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	26.93	29.29	19.61	0.24	1.42	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	13.44	15.06	10.89	13.21	1.39	2.32	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	25.64	17.09	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	14.80	15.41	6.88	0.31	1.75	0.00	0.62
mesothelioma cell line:Mero-25	10850-111F4	23.60	35.40	9.99	2.95	1.82	1.82	0.23
mesothelioma cell line:Mero-41	10851-111F5	38.38	21.51	23.96	0.00	1.71	0.00	0.98
mesothelioma cell line:Mero-48a	10852-111F6	29.45	24.36	19.71	0.44	1.55	0.22	0.66
mesothelioma cell line:Mero-82	10853-111F7	18.92	16.56	24.18	0.79	0.53	0.00	0.53
mesothelioma cell line:Mero-83	10854-111F8	12.60	18.04	8.68	1.36	0.68	0.17	0.51
mesothelioma cell line:Mero-84	10855-111F9	38.42	21.49	16.18	4.30	3.03	1.01	0.76
mesothelioma cell line:Mero-95	10856-111G1	28.78	23.40	16.77	1.86	2.07	0.41	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	22.53	14.74	13.25	0.00	1.82	0.00	0.50
mesothelioma cell line:NCI-H226	10846-111E9	23.71	21.36	11.22	3.08	2.35	0.36	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	26.14	19.82	13.32	8.88	2.05	0.34	0.34
mesothelioma cell line:NCI-H28	10845-111E8	18.58	21.12	14.50	4.07	1.53	0.76	0.76
mesothelioma cell line:No36	10857-111G2	13.37	10.76	13.70	0.00	1.30	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	18.70	17.88	11.65	0.54	1.63	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	23.61	9.02	8.83	0.19	1.15	0.00	0.58
migratory langerhans cells, donor2	11902-125F3	17.95	8.55	17.95	0.00	1.83	0.00	0.12
migratory langerhans cells, donor3	11903-125F4	16.69	9.33	12.56	0.18	1.26	0.18	0.90
mixed mullerian tumor cell line:HTMMT	10689-109F5	27.10	44.40	39.83	0.00	1.96	0.00	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	9.96	20.35	14.84	0.00	1.70	0.00	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	22.11	26.95	15.89	1.15	0.92	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	28.73	28.73	13.32	4.76	2.09	3.62	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	22.36	14.23	17.92	0.00	1.29	0.00	0.55
myeloma cell line:PCM6	10474-106I6	19.96	22.14	17.79	0.00	1.98	0.00	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	31.45	21.81	15.73	0.51	2.03	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	21.77	32.36	30.21	0.78	2.35	0.20	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	15.93	25.85	15.60	2.23	1.56	0.11	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	18.24	19.56	13.09	1.47	1.99	0.00	0.29
nasal epithelial cells, donor2	12227-129F4	34.22	29.26	46.92	2.21	2.76	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	12.88	13.34	20.48	14.26	0.92	4.14	0.23
neuroblastoma cell line:NB-1	10539-107G8	26.19	30.49	14.78	3.74	2.25	1.12	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	15.82	12.65	36.27	10.76	0.84	1.90	0.63
neuroblastoma cell line:NH-12	10555-107I6	22.92	30.93	25.34	16.21	1.68	2.61	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	18.27	20.16	17.08	1.66	0.24	0.00	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	13.94	27.40	30.88	4.28	1.43	0.00	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	15.50	60.58	32.60	6.64	2.21	1.01	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	31.15	52.13	36.87	1.91	1.27	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	28.21	44.98	19.43	1.33	1.60	0.00	0.27
neutrophil PMN, donor1	12133-128D9	119.00	178.50	104.12	14.87	29.75	29.75	0.00
neutrophil PMN, donor2	12137-128E4	106.25	26.56	0.00	0.00	0.00	0.00	13.28
neutrophil PMN, donor3	12141-128E8	132.59	66.29	28.41	18.94	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	15.90	15.73	17.42	4.40	1.35	1.01	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	33.62	16.81	28.82	0.80	0.00	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	27.57	37.19	21.16	4.49	1.60	0.64	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	34.42	21.81	33.90	2.63	2.10	0.79	1.58
nucleus accumbens, adult, pool1	10037-101F1	14.25	14.15	15.28	2.06	0.94	0.66	0.00
occipital cortex - adult, donor10196	10172-103C1	20.60	20.60	10.30	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	37.30	20.93	18.25	2.68	5.64	0.00	0.81
occipital cortex, newborn, donor10223	10355-105E4	18.56	17.47	6.91	0.73	0.36	1.09	0.00
occipital lobe, adult, donor1	10076-102A4	11.28	27.55	16.53	1.57	1.57	0.26	0.79
occipital lobe, fetal, donor1	10073-102A1	27.46	76.38	24.03	3.43	3.86	0.43	2.57
occipital pole, adult, pool1	10036-101E9	15.85	11.83	12.93	1.89	1.18	0.32	0.08
olfactory region, adult	10195-103E6	23.50	20.44	18.15	1.91	1.91	0.19	0.19
optic nerve, donor1	10277-104E7	16.01	10.01	22.01	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	14.92	14.12	9.57	0.00	1.14	0.11	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	17.45	22.67	22.12	0.00	1.92	0.00	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	17.27	17.27	9.82	0.00	0.85	0.00	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	35.58	35.46	41.81	0.12	3.12	0.23	0.81
osteoclastoma cell line:Hs 706.T	10704-109H2	33.81	20.58	27.04	0.88	2.06	0.88	4.12
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	14.95	6.54	16.82	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	13.78	12.09	9.97	0.21	1.27	0.00	0.21
ovary, adult, pool1	10020-101D2	27.87	17.91	19.74	1.05	2.18	0.09	0.96
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	14.48	33.91	17.23	0.00	1.28	0.00	0.00
pancreas, adult, donor1	10049-101G4	21.63	26.34	14.11	0.00	0.94	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	20.69	18.45	17.05	0.00	0.28	0.00	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	23.68	24.19	14.99	0.68	1.02	0.00	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	10.93	5.46	8.61	0.00	0.50	0.00	0.17
paracentral gyrus, adult, pool1	10035-101E8	14.37	11.44	16.02	1.28	0.82	0.27	0.18
parietal cortex, adult, donor10258	10373-105G4	22.02	22.02	11.74	0.73	0.00	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	21.63	12.23	11.29	0.00	1.88	0.94	0.94
parietal lobe, adult, donor10252	10157-103A4	25.94	15.11	12.54	1.43	1.71	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	14.36	11.54	13.75	1.67	1.50	0.09	0.18
parietal lobe, fetal, donor1	10072-101I9	33.94	85.35	14.55	0.97	1.94	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	19.81	16.08	10.84	1.12	1.12	0.37	0.37
parotid gland, adult	10199-103F1	67.22	22.82	45.02	12.95	3.08	0.00	0.62
penis, adult	10200-103F2	15.04	6.98	20.41	1.61	0.00	0.00	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	34.03	27.15	28.08	16.55	1.30	1.12	1.30
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	41.96	56.24	30.45	0.00	4.52	0.15	0.15
pineal gland - adult, donor10196	10179-103C8	7.10	7.10	1.94	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	7.11	7.11	3.55	0.00	1.18	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	9.41	6.27	1.88	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	27.32	43.51	15.18	2.02	3.04	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	32.83	27.62	11.47	3.13	3.65	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	28.09	24.69	11.07	3.40	1.70	0.00	0.00
placenta, adult, pool1	10021-101D3	21.39	11.83	17.42	0.43	1.61	0.22	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	17.75	16.16	13.38	1.46	0.40	0.26	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	29.57	16.03	18.21	0.78	0.93	0.00	0.62
pons, adult, pool1	10033-101E6	6.80	3.96	12.39	0.52	0.77	0.17	0.34
postcentral gyrus, adult, pool1	10032-101E5	15.78	12.12	14.21	2.79	1.57	0.61	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	35.55	48.10	18.82	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	0.00	22.03	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	15.00	9.61	24.47	0.15	2.18	0.00	0.00
prostate cancer cell line:PC-3	10439-106E7	24.32	19.60	25.59	2.72	1.63	0.36	0.00
prostate, adult, pool1	10022-101D4	21.04	11.16	17.23	7.89	1.45	0.73	0.36
putamen, adult, donor10196	10176-103C5	43.44	38.24	25.02	3.54	4.49	0.24	0.24
putamen, adult, donor10252	10152-102I8	33.33	27.45	9.80	5.88	1.96	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	14.21	10.93	6.56	2.19	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	30.20	32.86	13.29	2.42	1.93	0.48	0.72
putamen, newborn, donor10223	10365-105F5	11.99	6.00	3.75	2.25	0.75	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	26.48	10.18	17.75	0.00	1.45	0.00	0.29
rectum, fetal, donor1	10067-101I4	16.69	38.95	23.65	1.39	1.39	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	21.20	8.90	17.81	1.27	1.27	0.00	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	28.99	15.33	9.94	2.07	2.07	0.00	0.00
retina, adult, pool1	10030-101E3	19.98	13.82	16.60	1.79	2.29	0.20	0.30
retinoblastoma cell line:Y79	10475-106I7	10.65	4.94	18.97	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	21.52	26.68	33.56	21.52	1.84	6.39	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	23.62	23.90	25.59	1.69	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	21.22	20.46	25.01	3.03	2.27	1.52	0.00
salivary acinar cells, donor1	11771-123I7	17.16	7.93	15.21	3.08	0.81	0.00	0.16
salivary acinar cells, donor2	11772-123I8	25.33	14.59	23.27	3.44	0.69	0.14	0.83
salivary acinar cells, donor3	11773-123I9	36.41	11.92	13.24	1.32	0.00	0.66	0.00
salivary gland, adult, pool1	10093-102C3	31.46	13.73	16.59	2.86	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	15.01	6.24	12.82	2.19	0.76	0.17	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	14.81	9.87	11.64	1.76	1.29	0.35	0.24
seminal vesicle, adult	10201-103F3	16.40	11.11	23.81	1.06	0.00	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	18.71	16.03	6.32	0.24	1.94	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	15.60	11.83	19.38	0.00	1.51	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	24.08	9.03	34.12	0.00	2.01	0.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	31.70	33.58	19.61	0.00	2.82	0.00	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	15.81	11.38	20.45	0.99	0.99	0.22	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	20.90	9.81	22.97	2.58	0.90	0.52	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	4.26	3.55	19.86	0.00	0.00	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	20.15	13.31	20.75	0.84	1.20	0.24	1.44
skeletal muscle, fetal, donor1	10066-101I3	23.12	51.26	13.07	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	47.50	74.64	20.36	0.00	13.57	0.00	0.00
skin, fetal, donor1	10065-101I2	15.78	18.94	22.72	0.63	1.26	0.63	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	28.68	49.03	31.35	0.00	2.33	0.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	17.97	51.69	11.98	19.54	2.52	4.73	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	28.72	39.71	34.31	20.24	2.12	2.31	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	10.38	9.40	10.88	11.04	0.66	2.47	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	14.80	16.89	22.36	2.09	0.00	0.64	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	27.02	33.78	32.47	10.24	0.65	5.67	0.44
small intestine, adult, pool1	10024-101D6	24.01	7.17	31.06	0.12	1.43	0.36	0.84
small intestine, fetal, donor1	10064-101I1	31.45	25.80	17.20	0.98	1.72	0.00	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	46.16	22.05	36.93	0.00	1.54	0.00	2.05
smooth muscle, adult, pool1	10048-101G3	17.57	11.37	14.22	1.03	1.03	0.26	0.26
somatostatinoma cell line:QGP-1	10781-110G7	30.82	56.02	14.47	3.75	1.88	0.54	0.27
spinal cord - adult, donor10196	10181-103D1	16.75	19.50	11.01	0.23	0.69	0.46	0.46
spinal cord, adult, donor10252	10159-103A6	22.08	12.62	8.67	0.79	2.37	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	11.76	13.84	3.46	0.69	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	31.10	40.25	27.44	2.44	1.22	0.61	1.83
spinal cord, newborn, donor10223	10359-105E8	24.34	18.37	7.81	0.46	0.92	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	26.88	44.81	19.27	1.79	3.29	0.15	0.30
spleen, adult, pool1	10025-101D7	31.28	16.08	16.96	1.32	2.86	0.66	1.43
spleen, fetal, pool1	10044-101F8	22.41	13.03	26.30	1.83	1.83	0.40	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	15.22	15.11	14.70	4.45	0.83	0.83	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	17.47	15.19	13.48	0.00	1.33	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	25.51	24.11	15.38	0.70	1.05	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	37.53	51.99	20.72	0.00	1.95	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	58.87	119.42	24.76	0.00	4.95	0.00	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	24.15	15.25	13.13	2.12	1.27	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	33.85	20.31	12.69	1.27	2.12	0.00	0.42
stomach, fetal, donor1	10062-101H8	18.16	34.18	19.22	0.00	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	21.08	17.66	21.08	3.99	2.28	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	108.55	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	28.25	14.95	12.05	1.45	3.32	0.21	0.00
substantia nigra, adult, donor10258	10371-105G2	10.86	10.35	10.86	0.52	0.52	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	19.78	15.54	11.31	0.00	1.41	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	27.05	17.19	29.12	3.21	0.92	0.69	0.23
temporal lobe, adult, pool1	10031-101E4	22.21	18.48	17.04	1.95	1.70	0.34	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	43.45	71.94	27.78	0.00	4.27	0.00	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	41.32	33.84	37.80	2.64	1.76	0.00	0.00
tenocyte, donor1	11763-123H8	50.62	38.05	14.66	2.09	3.49	0.00	0.00
tenocyte, donor2	11765-123I1	48.07	20.98	12.21	1.91	2.29	0.00	0.38
tenocyte, donor3	11768-123I4	49.67	25.58	12.60	3.71	7.04	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	15.30	33.65	25.32	2.89	1.36	1.70	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	10.02	32.68	23.12	0.00	0.77	0.15	0.62
teratocarcinoma cell line:PA-1	10807-111A6	10.07	33.17	15.34	0.00	0.93	0.00	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	12.44	22.09	10.66	0.76	1.52	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	12.10	24.58	12.10	12.48	1.13	1.51	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	10.36	8.62	11.12	0.22	0.44	0.00	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	16.94	28.34	18.89	0.00	0.98	0.33	0.33
testis, adult, pool1	10026-101D8	24.48	17.39	28.24	2.58	2.47	0.97	2.47
testis, adult, pool2	10096-102C6	20.75	16.24	32.93	3.16	0.90	0.90	0.45
thalamus - adult, donor10196	10168-103B6	11.04	18.77	13.25	0.00	0.00	0.00	1.10
thalamus, adult, donor10252	10154-103A1	30.48	17.66	12.82	2.03	4.38	0.16	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	15.40	7.70	12.32	0.00	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	10.87	15.97	11.69	1.15	0.66	0.16	0.33
thalamus, newborn, donor10223	10366-105F6	20.71	12.08	10.36	0.58	0.00	1.73	1.15
throat, adult	10209-103G2	15.73	8.49	25.72	1.50	0.75	1.00	1.50
throat, fetal, donor1	10061-101H7	30.78	38.70	22.24	3.05	2.44	0.00	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	20.47	14.31	29.01	1.79	2.78	0.40	0.60
thymus, adult, pool1	10027-101D9	25.55	13.62	28.13	0.50	1.69	0.00	1.69
thymus, fetal, pool1	10043-101F7	16.73	12.05	29.82	1.14	0.94	0.31	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	23.40	16.49	17.15	0.00	1.33	0.13	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	16.20	37.58	9.64	5.17	1.40	0.14	0.14
thyroid, adult, pool1	10028-101E1	25.47	21.93	16.70	0.75	2.89	0.09	0.65
thyroid, fetal, donor1	10060-101H6	29.53	44.82	9.49	0.26	1.05	0.00	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	12.32	6.16	21.56	3.08	0.00	0.00	3.08
tongue, adult	10203-103F5	26.05	10.00	20.70	0.70	1.63	0.23	1.63
tongue, fetal, donor1	10059-101H5	31.92	40.99	18.13	0.00	2.36	0.79	0.00
tonsil, adult, pool1	10047-101G2	15.53	7.11	35.46	3.71	0.80	0.30	0.40
trachea, adult, pool1	10029-101E2	31.25	11.94	21.76	1.15	2.37	0.25	0.57
trachea, fetal, donor1	10058-101H4	44.62	40.01	17.70	4.62	3.46	0.00	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	30.82	36.49	18.42	2.83	3.54	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	21.07	18.74	23.61	1.01	0.91	0.20	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	10.65	6.74	9.24	8.46	0.47	0.63	0.31
tridermal teratoma cell line:HGRT	10694-109G1	24.73	22.83	24.73	7.61	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	20.40	23.62	12.78	0.08	2.45	0.00	0.25
umbilical cord, fetal, donor1	10057-101H3	14.61	20.87	8.35	2.09	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	19.79	9.21	13.14	1.54	0.51	0.00	0.68
uterus, fetal, donor1	10055-101H1	48.12	40.95	19.45	3.58	2.05	0.00	1.02
vagina, adult	10204-103F6	31.66	16.80	12.92	0.65	2.58	0.65	1.29
vein, adult	10191-103E2	35.29	21.04	21.70	1.32	1.75	0.00	1.32
xeroderma pigentosum b cell line:XPL 17	10563-108A5	10.68	17.89	8.01	7.48	1.34	1.07	0.00